Cytokine Research in Depression: Principles, Challenges, and Open Questions
Open accessAbstract
2), pro-inflammatory or anti-inflammatory cytokines of patients with a depressive disorder to those of healthy controls. Additionally, multiple longitudinal studies have investigated cytokine levels during antidepressant treatment. According to the current literature, it seems that peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated and that interferon (IFN)-γ levels are lower in patients with depression compared to healthy controls. However, the overlap of cytokine values between acutely depressed patients, remitted and recovered patients and healthy controls is considerable. Thus, the discriminative power of cytokine concentrations between depressed and non-depressed people is likely weak. Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α. However, weight gain-inducing psychopharmacological substances, such as the antidepressant mirtazapine, have been reported to potentially increase the production of pro-inflammatory cytokines. Even though cytokines are often discussed as biomarkers for depression, they have also been shown to be altered in other psychiatric disorders. Moreover, many environmental, social, psychological, biological, and medical factors are also associated with cytokine changes. Thus, cytokine alterations seem extremely unspecific. The interpretation of the results of these studies remains a challenge because it is unknown which type of cells are most responsible for cytokine changes measured in the blood nor have the main target cells or target tissues been identified. The same cytokine can be produced by multiple cell types, and the same cell can produce various cytokines. Additionally, redundancy, synergy, antagonism, and signaling cascades of cytokine signaling must be considered. Cytokines might not be associated with the diagnosis of depression according to the currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses. Therefore, the currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research.
Verified 2026-10-06 · 2 references not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review explains cytokine biology and critically assesses cytokine research in depression, concluding that peripheral cytokine alterations are statistically associated with depression but too overlapping and unspecific to serve as individual biomarkers. It argues that current diagnostic categories may be a poor starting point for psychiatric cytokine research.
Key findings
- Meta-analytic evidence cited by the review indicates that patients with depression have elevated serum/plasma IL-6, IL-10, IL-12, IL-13, and TNF-α, and lower IFN-γ, compared with healthy controls; however, cytokine values overlap considerably between depressed, remitted/recovered, and healthy individuals.
- A cited meta-analysis of 45 longitudinal studies and more than 1,500 patients found that antidepressant treatment overall decreases peripheral IL-6, IL-10, and TNF-α, but the review notes that reductions in peripheral inflammation were not shown to be associated with antidepressant treatment response.
- Cytokine alterations are not specific to depression: elevated TNF-α has also been found in PTSD, anorexia nervosa, and acute relapse of schizophrenia, and many environmental, social, psychological, biological, and medical factors are associated with cytokine changes.
- In one cited study, mean TNF-α serum concentrations were 50.35 ± 78.01 pg/ml in depressed patients versus 33.80 ± 46.17 pg/ml in healthy controls, illustrating substantial within-group variation and overlapping ranges despite significant group differences.
Methods
- Narrative review; the authors did not apply strict selection criteria, instead selecting articles based on how comprehensive, innovative, clearly written, and informative they were for in-depth understanding and critical debate.
- Included original research, reviews, book chapters, and case reports; for the section on cytokine alterations in depression and other psychiatric disorders, they strictly included only the latest meta-analysis on cytokine levels for each diagnosis in the text and Table 2.
- The review synthesizes literature on cytokine biology, immune-brain signaling, cytokine alterations in depression and other psychiatric disorders, risk factors, confounders, and antidepressant/psychotherapy effects.
Limitations
- Stated: the review is narrative and did not use strict selection criteria; cytokine research shows conflicting results and high variance; it is often unclear which cells produce measured cytokines or which target cells/tissues are involved; cytokine alterations are extremely unspecific; current diagnostic systems may not be ideal for psychiatric cytokine research; few studies have measured cytokines in cerebrospinal fluid; and there is not enough literature to draw firm conclusions about the influence of certain antidepressants on peripheral cytokine levels in vivo.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal quality appraisal, and quantitative synthesis, so its conclusions depend on selected literature and cited meta-analyses rather than a reproducible systematic review process.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 212 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Peripheral levels of interleukin-6 are elevated in patients with depression compared to healthy controls.
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Peripheral levels of tumor necrosis factor-alpha are elevated in patients with depression compared to healthy controls.
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Interferon-gamma levels are lower in patients with depression than in healthy controls.
“interferon (IFN)-γ levels are lower in patients with depression compared to healthy controls”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“whereas IFN-γ levels are lower in patients with depression than healthy controls (2, 33, 61–63)”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Peripheral levels of interleukin-12 are elevated in patients with depression compared to healthy controls.
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Peripheral levels of interleukin-10 are elevated in patients with depression compared to healthy controls.
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Peripheral levels of interleukin-13 are elevated in patients with depression compared to healthy controls.
“peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated”
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Affective Disorders · plain
- Premisecitation
Cytokines have been implicated in the pathology of depression.
“Cytokines have been implicated in the pathology of depression.”
- Also stated in: § Influence on Neurotransmitter Metabolism and Signaling · plain
“Given that peripheral production of cytokines has been associated with depression (2, 81)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [81] Lichtblau, 2013, Cytokines as biomarkers in depressive disorder: current standing and prospects, Int Rev Psychiatry source
Not checked in the free run.
- Also stated in: § Influence on Neurotransmitter Metabolism and Signaling · plain
- Premisecitation
Not all studies have found elevated tumor necrosis factor-alpha in the serum or plasma of depressed patients.
“such positive results have not been obtained by all studies”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Premisecitation
Results of cytokine research which are partly contradicting and often difficult to interpret have also been obtained in post-traumatic stress disorder and eating disorders.
“Results of cytokine research which are partly contradicting and often difficult to interpret have also been obtained in post-traumatic stress disorder (PTSD) (34–36) and eating disorders (37).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [34] Hussein, 2017, A systematic review of tumor necoris factor-α in post-traumatic stress disorder: evidence from human and animal studies, Psychiatr Danub. source
Not checked in the free run.
- cites [35] Waheed, 2018, A systematic review of interleukin-1β in post-traumatic stress disorder: evidence from human and animal studies, J Interfer Cytokine Res. source
Not checked in the free run.
- cites [36] Passos, 2015, Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression, Lancet Psychiatry source
Not checked in the free run.
- cites [37] Dalton, 2018, A meta-analysis of cytokine concentrations in eating disorders, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Treatment with certain antidepressants appears to decrease peripheral levels of interleukin-10.
“Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Premisecitation
Heterogeneity of results between studies on tumor necrosis factor-alpha in depression is large.
“heterogeneity of the results between studies is large (2)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Interpretationreasoning
The discriminative power of cytokine concentrations between depressed and non-depressed people is likely weak.
“Thus, the discriminative power of cytokine concentrations between depressed and non-depressed people is likely weak.”
Quote in the paperSubstantial claim - Premisecitation
One cytokine can act on multiple cell types and have different effects on these cells.
“One cytokine can act on multiple cell types and have different effects on these cells (48).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Tracey, 1994, Tumor necrosis factor: a pleiotropic cytokine and therapuetic target, Ann Rev Med. source
Not checked in the free run.
- Interpretationreasoning
It is unknown which type of cells are most responsible for cytokine changes measured in the blood.
“it is unknown which type of cells are most responsible for cytokine changes measured in the blood”
Quote in the paperSubstantial claim - Interpretationreasoning
Cytokine alterations seem extremely unspecific.
“Thus, cytokine alterations seem extremely unspecific.”
Quote in the paperSubstantial claim - Premisecitation
Cytokines have been shown to be altered in other psychiatric disorders.
“they have also been shown to be altered in other psychiatric disorders.”
- Also stated in: § Cytokine Alterations in Patients With Psychiatric Disorders in General · plain
“The aforementioned cytokine alterations in affective disorders are not specific to major depression or bipolar disorder.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther. source
Not checked in the free run.
- cites [38] Goldsmith, 2016, A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression, Mol Psychiatry source
Not checked in the free run.
- Also stated in: § Cytokine Alterations in Patients With Psychiatric Disorders in General · plain
- Premisecitation
Treatment with certain antidepressants appears to decrease peripheral levels of interleukin-6.
“Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Premisecitation
Treatment with certain antidepressants appears to decrease peripheral levels of tumor necrosis factor-alpha.
“Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Interpretationnone given
The main target cells or target tissues of cytokines in depression have not been identified.
“nor have the main target cells or target tissues been identified”
Quote in the paperSubstantial claim - Interpretationnone given
The overlap of cytokine values between acutely depressed, remitted and recovered patients and healthy controls is considerable.
“However, the overlap of cytokine values between acutely depressed patients, remitted and recovered patients and healthy controls is considerable.”
Quote in the paperSubstantial claim - Premisecitation
One single cell can produce different cytokines.
“the same cell can produce various cytokines.”
- Also stated in: § Cytokine Release · plain
“Furthermore, one single cell can produce different cytokines. For example, TH2 cells can produce IL-3, IL-4, IL-5, IL-6, and IL-13 (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Del Prete, 1992, Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy, Allergy source
Not checked in the free run.
- Also stated in: § Cytokine Release · plain
- Premisecitation
Cytokines influence the synthesis of monoamines through disruption of tetrahydrobiopterin.
“Cytokines also influence the synthesis of monoamines through disruption of tetrahydrobiopterin, an essential enzyme co-factor to hydroxylases involved in monoamine synthesis.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [89] Zhu, 2006, The Proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters, Neuropsychopharmacology source
Not checked in the free run.
- cites [90] Zhu, 2005, p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process, J Biol Chem. source
Not checked in the free run.
- cites [91] Zhu, 2010, Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters, Neuropsychopharmacology source
Not checked in the free run.
- cites [92] Morón, 2003, Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity, J Neurosci. source
Not checked in the free run.
- Premisecitation
Cytokines can antagonize each other's effects.
“Cytokines can also antagonize each other's effects.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [56] Georas, 2005, T-helper cell type-2 regulation in allergic disease, Eur Respir J. source
Not checked in the free run.
- cites [57] Ito, 2005, TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med. source
Not checked in the free run.
- cites [58] Kane, 2015, Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies, Chronic Respir Dis. source
Not checked in the free run.
- Premisecitation
Peripherally produced cytokines can influence the central nervous system.
“peripherally produced cytokines can influence the central nervous system (CNS)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther. source
Not checked in the free run.
- cites [80] D'Mello, 2009, Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation, J Neurosci. source
Not checked in the free run.
- Premisecitation
Peripheral levels of interleukin-18 are elevated in patients with depression compared to healthy controls.
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Interpretationreasoning
The currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research.
“Therefore, the currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research.”
Quote in the paperNot a substantial claim - Premisecitation
Cytokines can decrease serotonin synthesis by activating indoleamine 2,3 dioxygenase, which breaks down tryptophan to kynurenin instead of serotonin.
“Cytokines can decrease serotonin synthesis by activating the enzyme indoleamine 2,3 dioxygenase (IDO) which breaks down tryptophan, the amino acid precursor of serotonin, to kynurenin (KYN) instead of metabolizing tryptophan to serotonin.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [87] Bonaccorso, 2002, Increased depressive ratings in patients with hepatitis c receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system, J Clin Psychopharmacol. source
Not checked in the free run.
- cites [88] Capuron, 2003, Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment, Biol Psychiatry source
Not checked in the free run.
- Premisecitation
Peripheral levels of soluble TNFR2 are elevated in patients with depression compared to healthy controls.
“patients with depression have elevated serum or plasma concentrations of IL-6, IL-10, IL-12, IL-13, IL-18, TNF-α, and its receptor soluble TNFR2 compared to healthy controls”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- cites [61] Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosomatic Med. source
Not checked in the free run.
- cites [62] Haase, 2015, Die Regulation des Immunsystems und immunprivilegierte Organe source
Not checked in the free run.
- cites [63] Breitbart, 2013, Depression, cytokines, and pancreatic cancer, Psycho Oncol. source
Not checked in the free run.
- Premisecitation
In bipolar disorder, Munkholm et al. found significantly higher serum or plasma levels of soluble TNFR1.
“In bipolar disorder, Munkholm et al. (116) found significantly higher serum or plasma levels of TNF-α, its receptor soluble TNFR1 and IL-4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
These cytokines have not been found to be elevated by all studies in patients with depression and bipolar patients.
“However, these cytokines have not been found to be elevated by all studies in patients with depression and bipolar patients (2, 116).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- cites [116] Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J Psychiatr Res. source
Not checked in the free run.
- Interpretationcitation
The cytokine alterations in affective disorders are not specific to major depression or bipolar disorder.
“The aforementioned cytokine alterations in affective disorders are not specific to major depression or bipolar disorder.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The directionality of the relationship between cytokines and psychiatric disorders has not yet been elucidated with certainty.
“Even though there is considerable evidence for an involvement of cytokines in the pathophysiology of many psychiatric disorders, the directionality of this relationship has not yet been elucidated with certainty.”
Quote in the paperSubstantial claim - Interpretationcitation
Cytokine changes might also be the consequence of a psychiatric disorder, for example treatment with psychopharmacological agents or weight changes.
“Nevertheless, cytokine changes might also be the consequence of a psychiatric disorder, for example they can be a consequence of treatment with psychopharmacological agents or of weight changes that appear during acute episodes of the disorder or during recovery (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] Himmerich, 2015, Weight gain and metabolic changes during treatment with antipsychotics and antidepressants, Endocr Metabol Immune Disorder Drug Targets source
Not checked in the free run.
- Premisecitation
Acute cytokine administration increases corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol release.
“Acute cytokine administration has been shown to increase corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and cortisol release”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [99] Besedovsky, 1996, Immune-neuro-endocrine interactions: facts and hypotheses, Endocr Rev. source
Not checked in the free run.
- cites [100] Pariante, 2001, Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biol Psychiatry source
Not checked in the free run.
- cites [101] Pace, 2007, Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression, Brain Behav Immun. source
Not checked in the free run.
- Premisecitation
Chronic cytokine administration is associated with a flattening of the diurnal cortisol curve.
“In contrast, chronic cytokine administration is associated with a flattening of the diurnal cortisol curve”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [102] Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J Natl Cancer Inst. source
Not checked in the free run.
- cites [103] Matthews, 2006, Diurnal cortisol decline is related to coronary calcification: CARDIA study, Psychosomatic Med. source
Not checked in the free run.
- cites [104] Raison, 2010, Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior, Mol Psychiatry source
Not checked in the free run.
- Premisecitation
Certain pro-inflammatory cytokines stimulate glutamate release by astrocytes.
“certain pro-inflammatory cytokines stimulate glutamate release by astrocytes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Hardingham, 2002, Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways, Nat Neurosci. source
Not checked in the free run.
- Premisecitation
Flattening of the diurnal cortisol curve has been linked to adverse behavioral effects and poor outcomes in several illnesses such as cardiovascular disorders and cancer.
“which has been linked to adverse behavioral effects and poor outcomes in several illnesses such as cardiovascular disorders and cancer (102–104)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [102] Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J Natl Cancer Inst. source
Not checked in the free run.
- cites [103] Matthews, 2006, Diurnal cortisol decline is related to coronary calcification: CARDIA study, Psychosomatic Med. source
Not checked in the free run.
- cites [104] Raison, 2010, Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior, Mol Psychiatry source
Not checked in the free run.
- Premisecitation
In bipolar disorder, Munkholm et al. found significantly higher serum or plasma levels of interleukin-4.
“In bipolar disorder, Munkholm et al. (116) found significantly higher serum or plasma levels of TNF-α, its receptor soluble TNFR1 and IL-4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Cytokines can affect neuroendocrine function by increasing hypothalamic-pituitary-adrenal axis activity.
“Cytokines can also affect neuroendocrine function by increasing hypothalamic-pituitary-adrenal (HPA) axis activity.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [99] Besedovsky, 1996, Immune-neuro-endocrine interactions: facts and hypotheses, Endocr Rev. source
Not checked in the free run.
- cites [100] Pariante, 2001, Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biol Psychiatry source
Not checked in the free run.
- cites [101] Pace, 2007, Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression, Brain Behav Immun. source
Not checked in the free run.
- Premisecitation
In bipolar disorder, Munkholm et al. found significantly higher serum or plasma levels of tumor necrosis factor-alpha.
“In bipolar disorder, Munkholm et al. (116) found significantly higher serum or plasma levels of TNF-α, its receptor soluble TNFR1 and IL-4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [116] Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Evidence is increasing that inflammation and specifically cytokine signaling play a role in the pathophysiology of psychiatric disorders.
“However, evidence is increasing that inflammation and specifically cytokine signaling play a role in the pathophysiology of psychiatric disorders.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] 2013, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet source
Not checked in the free run.
- Premisecitation
Genetic risk factors for psychiatric disorders are closely related to cytokines or other functions of the immune system.
“There is considerable evidence that genetic risk factors for psychiatric disorders are closely related to cytokines or other functions of the immune system.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] 2013, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet source
Not checked in the free run.
- Premisecitation
Pro-inflammatory cytokines can affect the release of neurotransmitters.
“Moreover, pro-inflammatory cytokines can affect the release of neurotransmitters (93).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Capuron, 2012, Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration, Arch General Psychiatry source
Not checked in the free run.
- Premisecitation
Glutamate can decrease brain-derived neurotrophic factor by binding to extra-synaptic NMDA receptors, which is pivotal for neurogenesis.
“Glutamate can have a detrimental effect on neurogenesis by binding to extra-synaptic NMDA receptors, leading to a decrease in brain-derived neurotrophic factor (BDNF), which is pivotal for neurogenesis (105).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Hardingham, 2002, Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways, Nat Neurosci. source
Not checked in the free run.
- Premisecitation
There is high variation in cytokine levels within groups of patients or healthy controls.
“If we take a closer look at the raw data of specific studies, we see high variation in cytokine levels within groups of patients or healthy controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Positron emission tomography studies have revealed that application of interferon-alpha leads to increases in basal ganglia glucose metabolism.
“Positron emission tomography (PET) studies have revealed that the application of IFN-α leads to increases in basal ganglia glucose metabolism (109, 110).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [109] Juengling, 2000, Prefrontal cortical hypometabolism during low-dose interferon alpha treatment, Psychopharmacology source
Not checked in the free run.
- cites [110] Capuron, 2007, Basal ganglia hypermetabolism and symptoms of fatigue during interferon-α therapy, Neuropsychopharmacology source
Not checked in the free run.
- Premisecitation
Depression and fatigue are the main side effects of treatment with interferon-alpha.
“depression and fatigue are the main side effects of treatment with IFN-α (111, 112).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [111] Brydon, 2008, Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans, Biol Psychiatry source
Not checked in the free run.
- cites [112] Majer, 2008, IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C, Brain Behav Immun. source
Not checked in the free run.
- Premisecitation
Cytokines can modulate serotonin signaling by increasing the expression and function of monoamine transporters.
“Furthermore, they can modulate serotonin signaling by increasing the expression and function of monoamine transporters which perform the re-uptake of synaptic serotonin (89–92).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [89] Zhu, 2006, The Proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters, Neuropsychopharmacology source
Not checked in the free run.
- cites [90] Zhu, 2005, p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process, J Biol Chem. source
Not checked in the free run.
- cites [91] Zhu, 2010, Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters, Neuropsychopharmacology source
Not checked in the free run.
- cites [92] Morón, 2003, Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity, J Neurosci. source
Not checked in the free run.
- Premisecitation
Interferon-alpha has been implicated in increased anterior cingulate cortex activation.
“IFN-α has also been implicated in increased ACC activation as evidenced by fMRI studies (113, 114)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [113] Harrison, 2009, Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity, Biol Psychiatry source
Not checked in the free run.
- cites [114] Capuron, 2005, Anterior cingulate activation and error processing during interferon-alpha treatment, Biol Psychiatry source
Not checked in the free run.
- Premisecitation
Anterior cingulate cortex activation is associated with increased anxiety, arousal, obsessive-compulsive disorder and bipolar affective disorder.
“such ACC activation is associated with increased anxiety, arousal, obsessive-compulsive disorder and bipolar affective disorder (108).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Eisenberger, 2004, Why rejection hurts: a common neural alarm system for physical and social pain, Trends Cogn Sci. source
Not checked in the free run.
- Premisecitation
Glutamate release by astrocytes has been shown to be affected by cytokines, potentially leading to excitotoxicity.
“For example, glutamate release by astrocytes has been shown to be affected by cytokines, potentially leading to excitotoxicity (94, 95).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [94] Ida, 2008, Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide, Neurosci Lett. source
Not checked in the free run.
- cites [95] Matute, 2006, Glutamate-mediated glial injury: Mechanisms and clinical importance, Glia source
Not checked in the free run.
- Premisecitation
CNS inflammation caused by infection can lead to the development of psychiatric symptoms or full-blown syndromes such as depressive or manic episodes.
“Studies have shown that CNS inflammation caused by infection can lead to the development of psychiatric symptoms (121) or full-blown syndromes such as depressive or manic episodes (122).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [121] Ramirez, 2005, Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes, Neurobiol Dis. source
Not checked in the free run.
- cites [122] Mufaddel, 2014, Psychiatric aspects of infectious diseases, Open J Psychiatry source
Not checked in the free run.
- Premisecitation
Important confounders influencing cytokine serum or plasma levels include aging, body weight, smoking, excessive alcohol consumption, and medication.
“Important confounders include aging, body weight, smoking, excessive alcohol consumption, and medication (183).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [183] Dugue, 1996, Preanalytical factors and the measurement of cytokines in human subjects, Int J Clin Lab Res. source
Not checked in the free run.
- Premisecitation
Treatment of physical disorders, including interferon-based or virostatic treatments for hepatitis C, chemotherapy for cancer, surgery, or transplantation, can lead to additional cytokine release.
“The treatment of physical disorders, e.g., interferon-based or virostatic treatments for hepatitis C (167, 197), chemotherapy for the treatment of cancer (168), surgery (169) or transplantation (170), can lead to additional cytokine release.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [167] Winckler, 2018, Influence of the inflammatory response on treatment of hepatitis C with triple therapy, Rev Soc Bras Med Trop. source
Not checked in the free run.
- cites [197] Murakami, 2016, Depressive symptoms as a side effect of Interferon-alpha therapy induced by induction of indoleamine 2,3-dioxygenase 1, Sci Rep. source
Not checked in the free run.
- cites [168] Seruga, 2008, Cytokines and their relationship to the symptoms and outcome of cancer, Nat Rev Cancer source
Not checked in the free run.
- Interpretationreasoning
The cytokine system seems to be involved in almost all possible predisposing or precipitating risk factors for depression that contribute to the presentation of the disorder.
“Thus, the cytokine system seems to be involved in almost all possible predisposing or precipitating risk factors for depression that contribute to the presentation of the disorder.”
Quote in the paperSubstantial claim - Interpretationcitation
Elevated levels of inflammation may contribute to the prevalence of neuropsychiatric disorders in obese and elderly populations.
“Several studies have shown that the elevated levels of inflammation may contribute to the prevalence of neuropsychiatric disorders in these populations (188–192).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [188] Capuron, 2008, Depressive symptoms and metabolic syndrome: is inflammation the underlying link?, Biol Psychiatry source
Not checked in the free run.
- cites [189] Sweat, 2008, C-reactive protein is linked to lower cognitive performance in overweight and obese women, Inflammation source
Not checked in the free run.
- cites [190] Yaffe, 2004, The metabolic syndrome, inflammation, and risk of cognitive decline, JAMA source
Not checked in the free run.
- cites [191] Godbout, 2009, Age and neuroinflammation: a lifetime of psychoneuroimmune consequences, Immunol Allergy Clin N Am. source
Not checked in the free run.
- cites [192] Layé, 2010, Polyunsaturated fatty acids, neuroinflammation and well being, Prostaglandins Leukot Essent Fatty Acids source
Not checked in the free run.
- Rests on an assumption: Both the obese and the elderly exhibit behavioral symptoms such as depression and cognitive dysfunction at an increased rate compared to the general population.
- Premisecitation
Smoking, excessive alcohol consumption, and drug abuse have been associated with inflammatory changes in the immune system, reflected by an increase of pro-inflammatory cytokines.
“Smoking (193), excessive alcohol consumption (148), and drug abuse (149) have been associated with inflammatory changes in the immune system, as reflected by an increase of pro-inflammatory cytokines.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [193] Johannsen, 2013, Smoking and inflammation: evidence for a synergistic role in chronic disease, Periodontol 2000 source
Not checked in the free run.
- cites [148] Heberlein, 2014, TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients?, Alcohol source
Not checked in the free run.
- cites [149] Moreira, Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10, Drug Alcohol Depend. source
Not checked in the free run.
- Premisecitation
Genome-wide association studies have identified immune pathway genes that significantly contribute to the risk of psychiatric disorders.
“Genome-wide association studies (GWAS) have identified immune pathway genes that significantly contribute to the risk of psychiatric disorders (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] 2013, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet source
Not checked in the free run.
- Premisecitation
Psychopharmacological medication, specifically agents that lead to weight gain, has been reported to activate cytokine production.
“Also, psychopharmacological medication, specifically those agents which lead to weight gain, have been reported to activate cytokine production (117, 194).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [117] Himmerich, 2015, Weight gain and metabolic changes during treatment with antipsychotics and antidepressants, Endocr Metabol Immune Disorder Drug Targets source
Not checked in the free run.
- cites [194] Kluge, 2009, Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever, Psychoneuroendocrinology source
Not checked in the free run.
- Interpretationcitation
Growing white adipose tissue infiltrated by macrophages could be a major source of pro-inflammatory cytokines in the context of increasing body weight during psychopharmacological treatment.
“As growing white adipose tissue becomes infiltrated by macrophages, this fatty tissue could be a major source of pro-inflammatory cytokines in the context of increasing body weight during psychopharmacological treatment (195).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [195] Berthold-Losleben, The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology, Curr Neuropharmacol. source
Not checked in the free run.
- Premisecitation
ω6 fatty acids promote the production of IL-1β, IL-6, and TNF-α.
“ω6 fatty acids, in contrast, promote the production of these pro-inflammatory cytokines.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Husted, 2016, The importance of n-6/n-3 fatty acids ratio in the major depressive disorder source
Not checked in the free run.
- Premisecitation
Acute or chronic stress can lead to an increased production of pro-inflammatory cytokines.
“A risk factor like acute or chronic stress could, for example, lead to an increased production of pro-inflammatory cytokines (115, 138–140)”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [115] Himmerich, 2013, Stress-induced cytokine changes in rats, Eur Cytokine Network source
Not checked in the free run.
- cites [138] Rohleder, 2014, Stimulation of systemic low-grade inflammation by psychosocial stress, Psychosomatic Med. source
Not checked in the free run.
- cites [139] Menard, 2017, Social stress induces neurovascular pathology promoting depression, Nat Neurosci. source
Not checked in the free run.
- cites [140] Levine, 2015, Childhood and later life stressors and increased inflammatory gene expression at older ages, Soc Sci Med. source
Not checked in the free run.
- Premisecitation
All risk factors for depression have been shown or suggested to be associated with alterations in cytokine production or cytokine signaling.
“Table 3 provides evidence from the scientific literature that all of these risk factors for depression have been shown or suggested to be associated with alterations in cytokine production or cytokine signaling.”
Quote in the paperSubstantial claim - Premisecitation
Normal aging is marked by chronic low-level inflammation characterized by over-expression of circulating pro-inflammatory factors.
“Normal aging is marked by chronic low-level inflammation characterized by over-expression of circulating pro-inflammatory factors (184, 185).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [184] Fagiolo, 1992, Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people, Ann N Y Acad Sci. source
Not checked in the free run.
- cites [185] Fagiolo, 1993, Increased cytokine production in mononuclear cells of healthy elderly people, Eur J Immunol. source
Not checked in the free run.
- Premisecitation
Pro-inflammatory cytokines can enter the brain and lead to changes in neurotransmitter systems involved in the development of depression, such as the serotonin system.
“and these cytokines could then enter the brain (31) and lead to changes in neurotransmitter systems involved in the development of depression, such as the serotonin system (82, 83, 85, 86, 182).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [31] Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther. source
Not checked in the free run.
- cites [82] Dunn, 1995, Cytokine effects on CNS biogenic amines, Neuroimmunomodulation source
Not checked in the free run.
- cites [83] Dunn, 1999, Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress, Adv Exp Med Biol. source
Not checked in the free run.
- Premisecitation
ω3 fatty acids can reduce the production of IL-1β, IL-6, and TNF-α.
“Another example of how food can influence the immune system is the anti-inflammatory effect of ω3 fatty acids, which can reduce the production of IL-1β, IL-6, and TNF-α.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Husted, 2016, The importance of n-6/n-3 fatty acids ratio in the major depressive disorder source
Not checked in the free run.
- Premisecitation
Chronic inflammation with increased circulating levels of cytokines is characteristic of obesity.
“Chronic inflammation with increased circulating levels of cytokines is also characteristic of obesity (162, 186, 187).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [162] Schmidt, 2015, Inflammatory cytokines in general and central obesity and modulating effects of physical activity, PLoS ONE source
Not checked in the free run.
- cites [186] Bastard, 1999, Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects, Circulation source
Not checked in the free run.
- cites [187] Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest. source
Not checked in the free run.
- Interpretationreasoning
The group effects of cytokine differences between depressed patients and healthy controls may not be relevant on an individual level.
“Thus, the mentioned group effects may not be relevant on an individual level.”
Quote in the paperSubstantial claim - Premisecitation
Patients with schizophrenia can also suffer from depressive symptoms.
“For example, patients with schizophrenia can also suffer from depressive symptoms (212).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [212] Lyngstad, 2018, Consequences of persistent depression and apathy in first-episode psychosis — A one-year follow-up study, Comprehen Psychiatry source
Not checked in the free run.
- Premisenone given
A number of environmental, social, psychological, and medical factors are also associated with cytokine changes.
“Moreover, a number of environmental, social, psychological and medical factors (see Table 3) are also associated with cytokine changes.”
Quote in the paperSubstantial claim - Premisecitation
In vitro studies clearly show that antidepressants, antipsychotics, and mood stabilizers have a direct influence on cytokine production within the blood.
“What in vitro studies clearly show, however, is that antidepressants (69), antipsychotics (208) and mood stabilizers (209) have a direct influence on cytokine production within the blood.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [69] Munzer, 2013, Impact of antidepressants on cytokine production of depressed patients in vitro, Toxins source
Not checked in the free run.
- cites [208] Himmerich, 2011, Impact of antipsychotics on cytokine production in-vitro, J Psychiatr Res. source
Not checked in the free run.
- cites [209] Himmerich, 2013, Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro, J Psychiatr Res. source
Not checked in the free run.
- Interpretationreasoning
Cytokines may currently not be considered as specific biomarkers for depression.
“Therefore, cytokines may currently not be considered as specific biomarkers for depression.”
Quote in the paperSubstantial claim - Premisecitation
Attempts to try cytokine blockers in people with depression did not show striking success.
“However, attempts to try cytokine blockers in people with depression did not show striking success (218).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [218] Schmidt, 2014, The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases, Psychiatr Danub.
Not checked in the free run.
- Premisecitation
Antipsychotics with the highest risk of weight gain, such as clozapine and olanzapine, lead to a significant increase in pro-inflammatory cytokine levels in the blood.
“Among antipsychotics, it has been shown that those with the highest risk of weight gain, for example clozapine and olanzapine (117), lead to a significant increase in pro-inflammatory cytokine levels in the blood (194).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [117] Himmerich, 2015, Weight gain and metabolic changes during treatment with antipsychotics and antidepressants, Endocr Metabol Immune Disorder Drug Targets source
Not checked in the free run.
- cites [194] Kluge, 2009, Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever, Psychoneuroendocrinology source
Not checked in the free run.
- Premisecitation
The meta-analysis by Köhler et al. did not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response.
“Regarding changes of cytokine levels during antidepressant treatment, the aforementioned recent meta-analysis of Köhler et al. (2) did not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Premisecitation
TNF-α can be produced by white blood cells, the endothelium, fat cells, and other cells.
“For example, TNF-α can be produced by white blood cells, the endothelium, fat cells and other cells (46).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Perskidskii, 1992, Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases, Arkhiv Patologii
Not checked in the free run.
- Premisecitation
Del Grande da Silva et al. reported a clinical study showing that successful brief psychodynamic psychotherapy leads to a reduction of pro-inflammatory cytokine serum levels.
“For example, Del Grande da Silva et al. (211) reported a clinical study showing that successful brief psychodynamic psychotherapy leads to a reduction of pro-inflammatory cytokine serum levels.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [211] Del Grande da Silva, 2016, Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial, J Psychiatric Res. source
Not checked in the free run.
- Premisecitation
Animal experiments have shown that cytokine blockers like TNF-α blockers can be effective in the treatment of depression-like behavior.
“Animal experiments have shown that cytokine blockers like TNF-α blockers can be effective in the treatment of depression-like behavior (217).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [217] Krügel, 2013, Antidepressant effects of TNF-α blockade in an animal model of depression, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Only few studies have measured cytokine concentrations in the cerebrospinal fluid.
“At this point, we would like to mention that there are only few studies available that measured cytokine concentrations in the cerebrospinal fluid [e.g., (216)], even though one would assume that cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [216] Kern, 2014, Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample, Brain Behav Immun. source
Not checked in the free run.
- The authors state this as an assumption: Cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.
- Premisecitation
The SSRI citalopram increased the production of IL-1β, IL-6, and TNF-α in an in vitro study.
“However, the SSRI citalopram increased the production of IL-1β, IL-6, and TNF-α in another in vitro study (69).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Munzer, 2013, Impact of antidepressants on cytokine production of depressed patients in vitro, Toxins source
Not checked in the free run.
- Premisecitation
Jha et al. found that higher baseline levels of IL-17 were associated with greater symptomatic reduction in depressed patients treated with a bupropion-SSRI combination.
“For example, Jha et al. (210) found that higher baseline levels of IL-17 were associated with greater symptomatic reduction in depressed patients treated with a bupropion-SSRI combination.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [210] Jha, 2017, Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection, Brain Behav Immun. source
Not checked in the free run.
- Interpretationreasoning
There is currently not enough scientific literature to draw firm conclusions about the influence of certain antidepressants on plasma or serum levels of cytokines in vivo.
“There is currently not enough scientific literature available to draw firm conclusions about the influence of certain antidepressants on plasma or serum levels of cytokines in vivo.”
Quote in the paperSubstantial claim - Premisecitation
A meta-analysis of 45 longitudinal studies and more than 1,500 patients found that antidepressant treatment overall decreases peripheral levels of IL-6, IL-10, and TNF-α.
“However, a recent meta-analysis which included data derived from 45 longitudinal studies and more than 1,500 patients found that antidepressant treatment, overall, decreases peripheral levels of IL-6, IL-10, and TNF-α (2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
- Interpretationcitation
The described effects of antidepressants on certain cytokines may be a mere pharmacological effect on immune cells that is not necessarily related to the depressive syndrome.
“Additionally, the described effects of antidepressants on certain cytokines may be a mere pharmacological effect of these medications on immune cells that is not necessarily related to the depressive syndrome, as it has been shown that antidepressants (69), antipsychotics (208), and mood stabilizers (209) influence cytokine production directly.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [69] Munzer, 2013, Impact of antidepressants on cytokine production of depressed patients in vitro, Toxins source
Not checked in the free run.
- cites [208] Himmerich, 2011, Impact of antipsychotics on cytokine production in-vitro, J Psychiatr Res. source
Not checked in the free run.
- cites [209] Himmerich, 2013, Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro, J Psychiatr Res. source
Not checked in the free run.
- Premisecitation
Immune cells are not the only cells that release cytokines.
“During the 1970s it became clear that immune cells are not the only cells that release cytokines (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Cohen, 1974, Similarities of T cell function in cell-mediated immunity and antibody production, Cell Immunol. source
Not checked in the free run.
- Premisecitation
Gupta et al. found that successful treatment with mirtazapine led to a decrease in serum TNF-α levels.
“In contrast, however, Gupta et al. (203) found that successful treatment with mirtazapine led to a decrease in serum TNF-α levels.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] Gupta, 2016, Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-a in patients of major depressive disorder with severe depression, Pharmacology source
Not checked in the free run.
- May combine two claims. 30
- Classified as probably not a substantial claim. 9
May combine two claims.
PremisereasoningThe categories TH1, TH2, pro-inflammatory, and anti-inflammatory are neither distinct nor generally accepted categories for the classification of cytokines.
“Even though these categories are often referred to in the psychoimmunological literature, these are neither distinct nor generally accepted categories for the classification of cytokines.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningCytokines might not be associated with the diagnosis of depression according to currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses.
“Cytokines might not be associated with the diagnosis of depression according to the currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe same cytokine can be produced by multiple cell types.
“The same cytokine can be produced by multiple cell types.”
- Also stated in: § Cytokine Release · plain
“The same cytokine can be produced by multiple cell types. For instance, TNF-α is released by white blood cells, the endothelium, fat cells and other cells (46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Perskidskii, 1992, Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases, Arkhiv Patologii
Not checked in the free run.
- Also stated in: § Cytokine Release · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThis review did not apply strict selection criteria for the inclusion of articles.
“This is a narrative review; therefore, we did not apply strict selection criteria for the inclusion of certain articles.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCytokine signaling shows redundancy, because two or more cytokines can have a similar function.
“Cytokine signaling shows redundancy, because two or more cytokines can have a similar function.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Bruserud, 1992, IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: Studies of patients with chronic myelogenous leukaemia, Eur J Haematol. source
Not checked in the free run.
May combine two claims.
Interpretationnone givenCytokine research in psychiatry faces difficulties such as conflicting results and high variance of cytokine values within samples.
“Cytokine research in psychiatry faces several difficulties, such as conflicting results and high variance of cytokine values within samples.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCytokine cascades play a significant role in cytokine signaling.
“Additionally, cytokine cascades play a significant role in cytokine signaling which means that an activation of one cytokine produced by one cell type induces cytokine production by other cell types.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Lorentz, 2001, Regulation of human intestinal mast cells by stem cell factor and IL-4, Immunol Rev. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCytokine signaling shows synergy, a strong combined effect of two cytokines when acting together.
“Another typical phenomenon in cytokine signaling is synergy which is a strong combined effect of 2 cytokines when acting together”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Del Prete, 1992, Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy, Allergy source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor the section on cytokine alterations, the review strictly included only the latest meta-analysis on cytokine levels for each diagnosis in the text and Table 2.
“Regarding the section on cytokine alterations in depression and other psychiatric disorders, we strictly included only the latest meta-analysis on cytokine levels for each diagnosis in the text and in Table 2.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductcitationMost studies measure serum or plasma cytokine levels, but it has often been discussed whether these results reflect the situation in the brain.
“Most of the studies measure serum or plasma cytokine levels, but it has often been discussed whether these results reflect the situation in the brain (31).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther. source
Not checked in the free run.
May combine two claims.
PremisecitationCytokines can have different effects on different cells and thus may have pro- but also anti-inflammatory properties.
“One must also take into account that cytokines can have different effects on different cells and thus may have pro- but also anti-inflammatory properties.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [78] de Waal Malefyt, 1993, Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10, J Immunol. source
Not checked in the free run.
- cites [79] Tilg, 1996, Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine, Leukem Lymphoma source
Not checked in the free run.
May combine two claims.
PremisecitationElevated levels of tumor necrosis factor-alpha have also been found in PTSD studies, in patients with anorexia nervosa and in patients with acute relapse of schizophrenia.
“For example, elevated levels of TNF-α have also been found in PTSD studies (34), in patients with anorexia nervosa (37) and in patients with acute relapse of schizophrenia (31, 38).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [34] Hussein, 2017, A systematic review of tumor necoris factor-α in post-traumatic stress disorder: evidence from human and animal studies, Psychiatr Danub. source
Not checked in the free run.
- cites [37] Dalton, 2018, A meta-analysis of cytokine concentrations in eating disorders, J Psychiatr Res. source
Not checked in the free run.
- cites [31] Capuron, 2011, Immune system to brain signaling: neuropsychopharmacological implications, Pharmacol Ther. source
Not checked in the free run.
- cites [38] Goldsmith, 2016, A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression, Mol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationCorticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol have been found to be elevated in patients with major depression.
“all of which have been found to be elevated in patients with major depression (99–101)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [99] Besedovsky, 1996, Immune-neuro-endocrine interactions: facts and hypotheses, Endocr Rev. source
Not checked in the free run.
- cites [100] Pariante, 2001, Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biol Psychiatry source
Not checked in the free run.
- cites [101] Pace, 2007, Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression, Brain Behav Immun. source
Not checked in the free run.
May combine two claims.
InterpretationcitationDespite the significant difference between the means of both groups, depressed participants and healthy controls did not have distinct TNF-alpha levels, but rather overlapping ranges of TNF-alpha levels.
“This range indicates that, despite the significant difference between the means of both groups, depressed participants and healthy controls did not have distinct TNF-α levels, but rather overlapping ranges of TNF-α levels.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Schmidt et al., mean TNF-alpha serum concentrations of depressed patients were 50.35 pg/ml with a standard deviation of 78.01 pg/ml, whereas mean TNF-alpha levels of healthy controls were 33.80 ± 46.17 pg/ml.
“For example, in a paper published by Schmidt et al. (33), mean TNF-α serum concentrations of depressed patients were 50.35 pg/ml with a standard deviation of 78.01 pg/ml, whereas mean TNF-α levels of healthy controls were 33.80 ± 46.17 pg/ml.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Schmidt, 2014, Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity, J Psychiatr Res. source
Not checked in the free run.
May combine two claims.
PremisecitationMolecules produced by microbiota, such as LPS, can induce cytokine production and lead to depressive symptoms.
“Molecules produced by microbiota, e.g. LPS, can induce cytokine production (198), and lead to depressive symptoms (199).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [198] Bromberg, 2018, Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes, JCI Insight source
Not checked in the free run.
- cites [199] Reichenberg, 2001, Cytokine-associated emotional and cognitive disturbances in humans, Arch Gen Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationMany physical disorders have been reported to increase the risk for developing a depressive disorder and to activate the production of pro-inflammatory cytokines.
“Many physical disorders have been reported to increase the risk for developing a depressive disorder (125) and to activate the production of pro-inflammatory cytokines.”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [125] Himmerich, 2014, Prävention psychischer Erkrankungen am Beispiel der Depression
Not checked in the free run.
- cites [156] Rose-John, 2017, The role of IL-6 in host defence against infections: immunobiology and clinical implications, Nat Rev Rheumatol. source
Not checked in the free run.
- cites [157] Arango-Duque, 2014, Macrophage cytokines: involvement in immunity and infectious diseases, Front Immunol. source
Not checked in the free run.
- cites [158] Li, 2017, Innate lymphoid cell-derived cytokines in autoimmune diseases, J Autoimmun. source
Not checked in the free run.
- cites [159] Kuwabara, 2017, The Role of IL-17 and related cytokines in inflammatory autoimmune diseases, Mediator Inflamm. source
Not checked in the free run.
- cites [160] Igaz, 2000, Cytokines in diseases of the endocrine system, Cell Biol Int. source
Not checked in the free run.
May combine two claims.
PremisecitationVitamin D deficiency has been shown to increase pro-inflammatory cytokine production and to lead to depressive symptoms.
“Vitamin deficiency, e.g., vitamin D deficiency, has also been shown to increase pro-inflammatory cytokine production and to lead to depressive symptoms (133, 134).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [133] Grudet, 2014, Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood, Psychoneuroendocrinology source
Not checked in the free run.
- cites [134] Amini, 2018, Postpartum depression and vitamin D: a systematic review, Crit Rev Food Sci Nutr. source
Not checked in the free run.
May combine two claims.
PremisecitationIn the Whitehall II cohort study, inflammatory markers (CRP and IL-6) measured in British civil workers predicted symptoms of depression at follow-up, but symptoms of depression did not predict the inflammatory markers.
“The results of the Whitehall II cohort study in which British civil workers were monitored for CRP, IL-6 and cognitive symptoms of depression from 1991 to 2004 (baseline and follow-up) suggest that the inflammatory markers measured predicted symptoms of depression at follow-up, but not the other way around (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Gimeno, 2008, Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychological Med. source
Not checked in the free run.
May combine two claims.
PremisecitationAlcohol misuse and obesity are not only confounding factors, but also risk factors for the development of depression.
“One has to keep in mind, however, that alcohol misuse (148), obesity (163) are not only confounding factors, but also risk factors for the development of depression.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [148] Heberlein, 2014, TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients?, Alcohol source
Not checked in the free run.
- cites [163] Thormann, 2013, Obesity and depression: an overview on the complex interactions of two diseases, Fortschr Neurol Psychiatr. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe observation that inflammatory diseases can lead to psychiatric disorders such as depression is not recent; a meta-analytic scientific approach to such observations was published by Emil Kraepelin in 1881 and 1882.
“However, it must be mentioned that the observation that inflammatory diseases can lead to psychiatric disorders, such as depression, is not an achievement of recent decades of research: a meta-analytic scientific approach to such observations had already been published by Emil Kraepelin in 1881 and 1882 (123).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Steinberg, 2013, Emil Kraepelin's habilitation and his thesis: a pioneer work for modern systematic reviews, psychoimmunological research and categories of psychiatric diseases, World J Biol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationPsychiatrically relevant genes include those in the human leukocyte antigen gene complex or rare copy number variants important for immune function.
“Psychiatrically relevant genes include, for example, those in the human leukocyte antigen (HLA) gene complex or rare copy number variants important for immune function (119).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Piliero, 2003, T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11, Blood source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFoods with a high ratio of ω3/ω6 fatty acids can dampen inflammatory processes and thus potentially prevent or ameliorate depressive symptoms.
“Therefore, foods with a high ratio of ω3/ω6 fatty acids can dampen inflammatory processes and thus potentially prevent or ameliorate depressive symptoms (135).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Husted, 2016, The importance of n-6/n-3 fatty acids ratio in the major depressive disorder source
Not checked in the free run.
May combine two claims.
PremisecitationGut microbes can produce certain neurotransmitters and influence the central neurochemistry of the brain and thus human behavior.
“Gut microbes have, for example, been found to be capable of producing certain neurotransmitters and of influencing the central neurochemistry of the brain and thus human behavior (136).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] Dinan, 2017, The microbiome-gut-brain axis in health and disease, Gastroenterol Clin North Am. source
Not checked in the free run.
May combine two claims.
PremisecitationAdipose tissue accumulates and activates macrophages and lymphocytes which secrete inflammatory factors.
“Adipose tissue is known to accumulate and activate macrophages and lymphocytes which secrete inflammatory factors (186, 187).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [186] Bastard, 1999, Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects, Circulation source
Not checked in the free run.
- cites [187] Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe meta-analytic results compare means of groups, and there is huge overlap of the distributions of cytokine levels of depressed patients and healthy controls.
“However, one has to take into account that these are results comparing means of groups. There is huge overlap of the distributions of cytokine levels of depressed patients and healthy controls”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningCytokine levels are not only elevated in depression, but also in other psychiatric disorders.
“This might be a reason for limited specificity of cytokines as biomarkers for a certain psychiatric diagnosis, because the mentioned cytokine levels are not only elevated in depression, but also in other psychiatric disorders (see Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAfter the discovery of IFN-α, it became clear that this cytokine can influence immunological processes in the brain even when peripherally administered and can be produced by cells within the brain.
“Shortly after the discovery of the first cytokine, IFN-α (12), it became clear that this cytokine was able to influence immunological processes in the brain even when peripherally administered (17, 18) and that it can be produced by cells within the brain (18).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [12] Isaacs, 1957, Virus interference. I. the interferon, Proc Royal Soc B Biol Sci. source
Not checked in the free run.
- cites [17] Hitchcock, 1960, Protection of mice against the lethal action of an encephalitis virus, BMJ source
Not checked in the free run.
- cites [18] Hitchcock, 1961, The production of interferon in brains of mice infected with an arthropod-borne virus, Virology source
Not checked in the free run.
May combine two claims.
PremisecitationCytokine signaling often shows redundancy, synergy, antagonistic effects, or signaling cascades.
“As cytokine signaling often shows redundancy (53–55), synergy (47), antagonistic effects (56–59) or signaling cascades (60), it seems advisable to take all cytokines that work together or against each other into account and thus measure a whole range instead of a single cytokine.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [53] Bruserud, 1992, IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: Studies of patients with chronic myelogenous leukaemia, Eur J Haematol. source
Not checked in the free run.
- cites [54] Boraschi, 1985, Arachidonic acid metabolism in macrophages: regulation by interferons and interleukin 1, Int J Immunopharmacol. source
Not checked in the free run.
- cites [55] Munk, 1995, Functions of T-cell subsets and cytokines in mycobacterial infections, Eur Respir J Suppl.
Not checked in the free run.
- cites [47] Del Prete, 1992, Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy, Allergy source
Not checked in the free run.
- cites [56] Georas, 2005, T-helper cell type-2 regulation in allergic disease, Eur Respir J. source
Not checked in the free run.
- cites [57] Ito, 2005, TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand, J Exp Med. source
Not checked in the free run.
- cites [58] Kane, 2015, Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies, Chronic Respir Dis. source
Not checked in the free run.
- cites [59] Krumm, 2014, Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses, Protein Sci. source
Not checked in the free run.
May combine two claims.
PremisecitationMirtazapine induced a significant increase in plasma levels of TNF-α and both soluble TNF receptors, whereas venlafaxine did not significantly alter plasma levels of TNF-α or soluble TNF receptors.
“Whereas, mirtazapine induced a significant increase in the plasma levels of TNF-α and both soluble TNF receptors, venlafaxine did not alter plasma levels of TNF-α, or soluble TNF receptors significantly (201).”
- Also stated in: § The Influence of Antidepressants on Cytokine Production · plain
“These findings that mirtazapine increases circulating TNF-α levels were supported by Kast et al. (202).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [201] Kraus, 2002, Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine, Pharmacopsychiatry source
Not checked in the free run.
- cites [202] Kast, 2003, Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels, General Hosp Psychiatry source
Not checked in the free run.
- Also stated in: § The Influence of Antidepressants on Cytokine Production · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe close relationship between inflammatory processes and psychiatric symptoms has been scientifically investigated since the 19th century.
“The close relationship between inflammatory processes and psychiatric symptoms has been scientifically investigated since the 19th century (123).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Steinberg, 2013, Emil Kraepelin's habilitation and his thesis: a pioneer work for modern systematic reviews, psychoimmunological research and categories of psychiatric diseases, World J Biol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationMany immunologically important cytokines, such as IL-21 and IL-22, have not been extensively researched in psychiatric samples yet, although preliminary studies have revealed promising results.
“There are many immunologically important cytokines like IL-21 (65) and IL-22 (66) which have not been extensively researched in psychiatric samples yet, even though the first preliminary studies have revealed promising results (67, 69).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [65] Leonard, 2016, IL-21 Signaling in immunity, F1000Res. source
Not checked in the free run.
- cites [66] Alabbas, 2018, The role of IL-22 in the resolution of sterile and nonsterile inflammation, Clin Transl Immunol. source
Not checked in the free run.
- cites [67] Juncal-Ruiz, 2018, Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study, Schizophr Res. source
Not checked in the free run.
May combine two claims.
PremisecitationIn vitro literature suggests that some antidepressants, such as clomipramine and fluoxetine, decrease IL-6, IFN-γ, and TNF-α, while others like mirtazapine and venlafaxine tend to increase their levels.
“The in vitro literature on antidepressants suggest that some antidepressants, such as clomipramine and fluoxetine, decrease IL-6, IFN-γ, and TNF-α, whilst others like mirtazapine and venlafaxine tend to increase their levels (207).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [207] Baumeister, 2016, Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?, Psychopharmacology source
Not checked in the free run.
May combine two claims.
InterpretationcitationWhen a specific cytokine like TNF-α is measured in serum or plasma, it is unclear from which cells or organ it is derived and where it will exert its effect, because one cytokine can have different effects on different cell types.
“Therefore, if we measure a specific cytokine like TNF-α in the serum or plasma, it is unclear from which cells or which organ it is derived and where this cytokine will exert its effect, as one cytokine can have different effects on different cell types (10).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Tracey, 1992, Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels, Exp Biol Med. source
Not checked in the free run.
May combine two claims.
PremisecitationMood stabilizers such as lithium and carbamazepine have been shown to lead to weight gain as well as an increase in pro-inflammatory cytokine levels.
“Some of these mood stabilizers, for example lithium and carbamazepine, have also been shown to lead to weight gain as well as an increase in pro-inflammatory cytokine levels (206).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [206] Himmerich, 2005, Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium, Psychopharmacology source
Not checked in the free run.
May combine two claims.
PremisecitationMeta-analytic research shows that peripheral levels of IL-6, IL-10, IL-12, IL-13, and TNF-α are significantly elevated and IFN-γ plasma concentrations are significantly lower in patients with depression compared to healthy controls.
“As peripheral levels of IL-6, IL-10, IL-12, IL13, and TNF-α have been shown to be significantly elevated and IFN-γ plasma concentrations significantly lower in patients with depression compared to healthy controls in meta-analytic research (2), one could think that cytokines qualify as a biomarker of depression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Köhler, 2017, Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis, Mol Neurobiol. source
Not checked in the free run.
May combine two claims.
PremisecitationChanges in specific cytokine-producing immune cells like Treg cells have been reported in depression and during antidepressant therapy.
“Cytokine levels are often researched and interpreted in isolation from their origin in terms of the specific cell type and the particular tissue they are originating from, even though changes in specific cytokine-producing immune cells like Treg cells have been reported in depression (213) and during antidepressant therapy (214).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [213] Li, 2010, Altered expression of CD4+CD25+ regulatory T cells and its 5-HT1a receptor in patients with major depression disorder, J Affect Disord. source
Not checked in the free run.
- cites [214] Himmerich, 2010, Regulatory T cells increased while IL-1β decreased during antidepressant therapy, J Psychiatr Res. source
Not checked in the free run.
The paper relies on this without support.
Both the obese and the elderly exhibit behavioral symptoms such as depression and cognitive dysfunction at an increased rate compared to the general population.
“Both the obese and the elderly exhibit behavioral symptoms such as depression and cognitive dysfunction at an increased rate compared to the general population.”
The paper relies on this without support.
People with depression exhibit heterogeneous sets of symptoms.
“People with depression exhibit heterogeneous sets of symptoms.”
The authors state this as an assumption.
Cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.
“even though one would assume that cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pro-inflammatory cytokines contribute to the pathogenesis of psychiatric diseases such as depression.
“Growing evidence suggests that pro-inflammatory cytokines contribute to the pathogenesis of psychiatric diseases such as depression [137,138]”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [138]
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · see citing works
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · see citing works
Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G
Engvall, E., & Perlmann, P. (1971) · Immunochemistry · doi:10.1016/0019-2791(71)90454-x · Cited by 3,785 · see citing works
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451 · see citing works
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010 · see citing works
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · see citing works
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708 · see citing works
Alexander, G. E., Crutcher, M. D., & DeLong, M. R. (1990) · PubMed · Cited by 2,422 · see citing works
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62678-3 · Cited by 1,961 · see citing works
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823 · see citing works
Construction of Biologically Functional Bacterial Plasmids In Vitro
Cohen, S. N., Chang, A. C. Y., Boyer, H. W., & Helling, R. B. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.11.3240 · Cited by 1,811 · see citing works
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · see citing works
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · see citing works
Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity
Bloom, B. R., & Bennett, B. P. (1966) · Science · doi:10.1126/science.153.3731.80 · Cited by 1,615 · see citing works
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564 · see citing works
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443 · see citing works
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365 · see citing works
David, J. R. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.1.72 · Cited by 1,282 · see citing works
Why rejection hurts: a common neural alarm system for physical and social pain
Eisenberger, N. I., & Lieberman, M. D. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.010 · Cited by 1,246 · see citing works
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195 · see citing works
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · see citing works
(1987) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(87)90455-5 · Cited by 1,130 · see citing works
Ito, T., Wang, Y.-H., Duramad, O., Hori, T., Delespesse, G. J., Watanabe, N., Qin, F. X.-F., Yao, Z., Cao, W., & Liu, Y.-J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051135 · Cited by 1,129 · see citing works
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · see citing works
The microbiome-gut-brain axis in health and disease
Dinan, T. G., & Cryan, J. F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.007 · Cited by 1,111 · see citing works
Assay of Plasma Insulin in Human Subjects by Immunological Methods
Yalow, R. S., & Berson, S. A. (1959) · Nature · doi:10.1038/1841648b0 · Cited by 1,098 · see citing works
Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
Sephton, S. E. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.994 · Cited by 1,082 · see citing works
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063 · see citing works
Social stress induces neurovascular pathology promoting depression
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0010-3 · Cited by 1,028 · see citing works
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · see citing works
Immunoassay using antibody—enzyme conjugates
Weemen, B. K. V., Schuurs, A. H. W. M., Oostermeijer, M. W., & Raymakers, H. H. T. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)81003-3 · Cited by 869 · see citing works
Immunoassay using antigen—enzyme conjugates
Weemen, B. K. V., & Schuurs, A. H. W. M. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80319-8 · Cited by 861 · see citing works
Acute phase response in animals: a review.
Cray, C., Zaias, J., & Altman, N. H. (2009) · PubMed Central · Cited by 816 · see citing works
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805 · see citing works
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794 · see citing works
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.015 · Cited by 756 · see citing works
Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743 · see citing works
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 730 · see citing works
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin
Wheelock, Ε. F. (1965) · Science · doi:10.1126/science.149.3681.310 · Cited by 725 · see citing works
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675 · see citing works
Increased cytokine production in mononuclear cells of healthy elderly people
Fagiolo, U., Cossarizza, A., Scala, E., Fanales‐Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., & Paganelli, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230950 · Cited by 665 · see citing works
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652 · see citing works
de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6370 · Cited by 648 · see citing works
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621 · see citing works
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617 · see citing works
Isaacs, A., & Lindenmann, J.-M. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602 · see citing works
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596 · see citing works
Stress, depression, and anhedonia: caveats concerning animal models
Anisman, H., & Matheson, K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.007 · Cited by 569 · see citing works
Gimeno, D., Kivimäki, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G. D. O., Rumley, A., Marmot, M. G., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003723 · Cited by 561 · see citing works
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549 · see citing works
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519 · see citing works
Szarka, A., Rigó, J., Lázár, L., Bekő, G., & Molvarec, A. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-59 · Cited by 516 · see citing works
Stimulation of systemic low-grade inflammation by psychosocial stress.
Rohleder, N. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000049 · Cited by 497 · see citing works
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493 · see citing works
Fonken, L. K., Xu, X., Weil, Z. M., Chen, G., Sun, Q., Rajagopalan, S., & Nelson, R. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.76 · Cited by 484 · see citing works
Inflammatory cytokines in general and central obesity and modulating effects of physical activity
Schmidt, F. M., Weschenfelder, J., Sander, C., Minkwitz, J., Thormann, J., Chittka, T., Mergl, R., Kirkby, K. C., Faßhauer, M., Stumvoll, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121971 · Cited by 483 · see citing works
Self-citationKöhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449 · see citing works
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437 · see citing works
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Rose-John, S., Winthrop, K., & Calabrese, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.83 · Cited by 424 · see citing works
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · see citing works
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 413 · see citing works
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Dale, R. C., Merheb, V., Pillai, S. C., Wang, D., Cantrill, L. C., Murphy, T. K., Ben‐Pazi, H., Varadkar, S., Aumann, T. D., Horne, M. K., et al. (2012) · Brain · doi:10.1093/brain/aws256 · Cited by 387 · see citing works
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382 · see citing works
Brydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381 · see citing works
Glutamate‐mediated glial injury: Mechanisms and clinical importance
Matute, C., Domercq, M., & Sánchez‐Gómez, M. V. (2005) · Glia · doi:10.1002/glia.20275 · Cited by 330 · see citing works
Prevention of major depression
Muñoz, R. F., Cuijpers, P., Smit, F., Barrera, A. Z., & Leykin, Y. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-033109-132040 · Cited by 326 · see citing works
IL‐17 and IL‐22 in immunity: Driving protection and pathology
Eyerich, K., Dimartino, V., & Cavani, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201646723 · Cited by 324 · see citing works
Astrocytes are GABAergic cells that modulate microglial activity
Lee, M., Schwab, C., & McGeer, P. L. (2010) · Glia · doi:10.1002/glia.21087 · Cited by 321 · see citing works
Zhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317 · see citing works
Effects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316 · see citing works
Genetics Factors in Major Depression Disease
Shadrina, M. I., Bondarenko, E. A., & Slominsky, P. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00334 · Cited by 300 · see citing works
Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial Infarction
Neri, M., Fineschi, V., Paolo, M. D., Pomara, C., Riezzo, I., Turillazzi, E., & Cerretani, D. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990003 · Cited by 296 · see citing works
Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy
Prete, G. D. (1992) · Allergy · doi:10.1111/j.1398-9995.1992.tb00662.x · Cited by 287 · see citing works
Lenze, E. J., Mulsant, B. H., Blumberger, D. M., Karp, J. F., Newcomer, J. W., Anderson, S. J., Dew, M. A., Butters, M. A., Stack, J. A., Begley, A. E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00308-6 · Cited by 283 · see citing works
Graham, A. M., Rasmussen, J. M., Rudolph, M. D., Heim, C. M., Gilmore, J. H., Styner, M., Potkin, S. G., Entringer, S., Wadhwa, P. D., Fair, D. A., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.027 · Cited by 282 · see citing works
Inflammatory and Immune Responses to Surgery and Their Clinical Impact
Alazawi, W., Pirmadjid, N., Lahiri, R. P., & Bhattacharya, S. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001691 · Cited by 282 · see citing works
(1924) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651991000200014 · Cited by 281 · see citing works
Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262 · see citing works
Bastard, J.-P., Jardel, C., Delattre, J., Hainque, B., Bruckert, E., & Oberlin, F. (1999) · Circulation · doi:10.1161/circ.99.16.2219/c · Cited by 244 · see citing works
Diurnal cortisol decline is related to coronary calcification: CARDIA study
Matthews, K., Schwartz, J., Cohen, S., & Seeman, T. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000244071.42939.0e · Cited by 240 · see citing works
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229 · see citing works
Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228 · see citing works
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Godbout, J. P., & Johnson, R. W. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.007 · Cited by 224 · see citing works
Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222 · see citing works
Cytokine receptor signaling pathways
Leonard, W. J., & Lin, J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106899 · Cited by 221 · see citing works
Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
Capuron, L., Su, S., Miller, A. H., Bremner, J. D., Goldberg, J., Vogt, G. J., Maisano, C., Jones, L., Murrah, N. V., & Vaccarino, V. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.019 · Cited by 219 · see citing works
Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381701 · Cited by 212 · see citing works
Human leukocyte interferon (HuIFN-α): Potent endorphin-like opioid activity
Blalock, J. E., & Smith, E. M. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91284-5 · Cited by 204 · see citing works
A meta-analysis of cytokine concentrations in eating disorders
Dalton, B., Bartholdy, S., Robinson, L., Solmi, M., Ibrahim, M. A. A., Breen, G., Schmidt, U., & Himmerich, H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.06.002 · Cited by 197 · see citing works
Self-citationSmoking and inflammation: evidence for a synergistic role in chronic disease
Johannsen, A., Susin, C., & Gustafsson, A. (2014) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00456.x · Cited by 194 · see citing works
Leonard, W. J., & Wan, C.-K. (2016) · F1000Research · doi:10.12688/f1000research.7634.1 · Cited by 184 · see citing works
Baumeister, D., Ciufolini, S., & Mondelli, V. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4044-5 · Cited by 183 · see citing works
Raison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183 · see citing works
T-helper cell type-2 regulation in allergic disease
Georas, S. N., Guo, J., De Fanis, U., & Casolaro, V. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00006005 · Cited by 181 · see citing works
Depression, comorbidities and the TNF-α system
Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Gedrich, K., Kloiber, S., Lucae, S., Ising, M., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.03.013 · Cited by 181 · see citing works
Self-citationCaraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172 · see citing works
Polyunsaturated fatty acids, neuroinflammation and well being
Layé, S. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.006 · Cited by 167 · see citing works
The potential role of neuroinflammation and transcription factors in Parkinson disease
Tiwari, P. C., & Pal, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/rpal · Cited by 167 · see citing works
Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples
Keustermans, G., Hoeks, S. B. E. A., Meerding, J., Prakken, B. J., & de Jager, W. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.005 · Cited by 166 · see citing works
Li, Y., Xiao, B., Qiu, W., Yang, L., Hu, B., Tian, X., & Yang, H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.018 · Cited by 163 · see citing works
Systematic Review of Proinflammatory Cytokines in Obsessive-Compulsive Disorder
Gray, S. M., & Bloch, M. H. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0272-0 · Cited by 162 · see citing works
Similarities of T cell function in cell-mediated immunity and antibody production
Cohen, S., Bigazzi, P. E., & Yoshida, T. (1974) · Cellular Immunology · doi:10.1016/0008-8749(74)90066-5 · Cited by 157 · see citing works
Cytokines as biomarkers in depressive disorder: current standing and prospects
Lichtblau, N., Schmidt, F. M., Schumann, R., Kirkby, K. C., & Himmerich, H. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.813442 · Cited by 155 · see citing works
Self-citationPrefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149 · see citing works
Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity
Schmidt, F. M., Lichtblau, N., Minkwitz, J., Chittka, T., Thormann, J., Kirkby, K. C., Sander, C., Mergl, R., Faßhauer, M., Stumvoll, M., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.021 · Cited by 146 · see citing works
Self-citationKluge, M., Schuld, A., Schacht, A., Himmerich, H., Dalal, M. A., Wehmeier, P. M., Hinze-Selch, D., Kraus, T., Dittmann, R. W., & Pollmächer, T. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.016 · Cited by 146 · see citing works
Self-citationKraus, T., Haack, M., Schuld, A., Hinze-Selch, D., Koethe, D., & Pollmächer, T. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-36390 · Cited by 144 · see citing works
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome
Piliero, L. M., Sanford, A. N., McDonald-McGinn, D. M., Zackai, E. H., & Sullivan, K. E. (2004) · Blood · doi:10.1182/blood-2003-08-2824 · Cited by 144 · see citing works
RAISON, C. L., WOOLWINE, B. J., DEMETRASHVILI, M. F., BORISOV, A. S., WEINREIB, R., STAAB, J. P., ZAJECKA, J. M., BRUNO, C. J., HENDERSON, M. A., REINUS, J. F., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03316.x · Cited by 142 · see citing works
The importance of n-6/n-3 fatty acids ratio in the major depressive disorder
Husted, K. S., & Bouzinova, E. V. (2016) · Medicina · doi:10.1016/j.medici.2016.05.003 · Cited by 142 · see citing works
Pharmacological treatment for psychotic depression
Wijkstra, J., Lijmer, J. G., Burger, H., Cipriani, A., Geddes, J. R., & Nolen, W. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004044.pub4 · Cited by 141 · see citing works
Targeting classical IL-6 signalling or IL-6<i>trans</i>-signalling in depression?
Maes, M., Anderson, G., Kubera, M., & Berk, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888417 · Cited by 140 · see citing works
Jaremka, L. M., Lindgren, M. E., & Kiecolt‐Glaser, J. K. (2013) · Depression and Anxiety · doi:10.1002/da.22078 · Cited by 137 · see citing works
Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124 · see citing works
Weight gain and metabolic changes during treatment with antipsychotics and antidepressants
Himmerich, H., Minkwitz, J., & Kirkby, K. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150623092031 · Cited by 122 · see citing works
Self-citationThe TNF-&#945; System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology
Berthold-Losleben, M., & Himmerich, H. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777238 · Cited by 119 · see citing works
Self-citationRegulatory T cells increased while IL-1β decreased during antidepressant therapy
Himmerich, H., Milenović, S., Fulda, S., Plümäkers, B., Sheldrick, A. J., Michel, T. M., Kircher, T., & Rink, L. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.005 · Cited by 116 · see citing works
Self-citationImpact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114 · see citing works
Self-citationSuicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood
Grudet, C., Malm, J., Westrin, Å., & Brundin, L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.016 · Cited by 112 · see citing works
Cortisol, cytokines, and hippocampal volume interactions in the elderly
Sudheimer, K. D., O'Hara, R. M., Spiegel, D., Powers, B. N., KRAEMER, H. C., Neri, E., Weiner, M. W., Hardan, A. Y., Hallmayer, J. F., & Dhabhar, F. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00153 · Cited by 111 · see citing works
Cytokine effects on CNS biogenic amines
Dunn, A. J., & Wang, J. (1996) · Neuroimmunomodulation · doi:10.1159/000097211 · Cited by 108 · see citing works
Ida, T., Hara, M., Nakamura, Y., Kozaki, S., Tsunoda, S., & Ihara, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.047 · Cited by 107 · see citing works
Stress-induced cytokine changes in rats
Himmerich, H., Fischer, J., Bauer, K., Kirkby, K. C., Sack, U., & Krügel, U. (2013) · European Cytokine Network · doi:10.1684/ecn.2013.0338 · Cited by 107 · see citing works
Self-citationDepression, cytokines, and pancreatic cancer
Breitbart, W., Rosenfeld, B., Tobias, K., Pessin, H., Ku, G. Y., Yuan, J., & Wolchok, J. (2014) · Psycho-Oncology · doi:10.1002/pon.3422 · Cited by 106 · see citing works
Childhood and later life stressors and increased inflammatory gene expression at older ages
Levine, M. E., Cole, S. W., Weir, D. R., & Crimmins, E. M. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.01.030 · Cited by 106 · see citing works
Functions of T-cell subsets and cytokines in mycobacterial infections.
Munk, M. E., & Emoto, M. (1995) · PubMed · Cited by 105 · see citing works
Impact of antipsychotics on cytokine production in-vitro
Himmerich, H., Schönherr, J., Fulda, S., Sheldrick, A. J., Bauer, K., & Sack, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.04.009 · Cited by 104 · see citing works
Self-citationAntidepressant effects of TNF-α blockade in an animal model of depression
Krügel, U., Fischer, J., Radicke, S., Sack, U., & Himmerich, H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.007 · Cited by 104 · see citing works
Self-citationImpact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro
Himmerich, H., Bartsch, S., Hamer, H., Mergl, R., Schönherr, J., Petersein, C., Munzer, A., Kirkby, K. C., Bauer, K., & Sack, U. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.026 · Cited by 100 · see citing works
Self-citationNeuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
Kaur, K., Gill, J. S., Bansal, P. K., & Deshmukh, R. R. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3251 · Cited by 98 · see citing works
Heberlein, A., Käser, M., Lichtinghagen, R., Rhein, M., Lenz, B., Kornhuber, J., Bleich, S., & Hillemacher, T. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.08.003 · Cited by 98 · see citing works
Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome
Tanaka, S., Kuratsune, H., Hidaka, Y., Hakariya, Y., Tatsumi, K., Takano, T., Kanakura, Y., & Amino, N. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.2.225 · Cited by 97 · see citing works
Krumm, B., Xiang, Y., & Deng, J. (2014) · Protein Science · doi:10.1002/pro.2441 · Cited by 95 · see citing works
Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.006 · Cited by 94 · see citing works
Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10
Moreira, F. P., Medeiros, J. R. C., Lhullier, A. C., Souza, L. D. D. M., Jansen, K., Portela, L. V., Lara, D. R., Silva, R. A. D., Wiener, C. D., & Oses, J. P. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.11.024 · Cited by 92 · see citing works
Clark, S. M., Pocivavsek, A., Nicholson, J. D., Notarangelo, F. M., LANGENBERG, P. W., McMahon, R. P., Kleinman, J. E., Hyde, T. M., Stiller, J. W., Postolache, T. T., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150226 · Cited by 92 · see citing works
Research Review: The role of cytokines in depression in adolescents: a systematic review
Mills, N. T., Scott, J. G., Wray, N. R., Cohen‐Woods, S., & Baune, B. T. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12080 · Cited by 91 · see citing works
Tracey, K. J., & Cerami, A. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43426 · Cited by 85 · see citing works
Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder
Tang, Z., Ye, G., Chen, X., Pan, M., Fu, J., Fu, T., Liu, Q., Gao, Z., Baldwin, D. S., & Hou, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.082 · Cited by 83 · see citing works
Cytokine alterations in panic disorder: A systematic review
Quagliato, L. A., & Nardi, A. E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.094 · Cited by 83 · see citing works
Regulation of human intestinal mast cells by stem cell factor and IL-4
Lorentz, A., & Bischoff, S. C. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.790106.x · Cited by 80 · see citing works
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79 · see citing works
Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
Barbierato, M., Facci, L., Argentini, C., Marinelli, C., Skaper, S. D., & Giusti, P. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990064 · Cited by 79 · see citing works
Fibroblast activation in vascular inflammation
Enzerink, A., & Vaheri, A. I. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04209.x · Cited by 75 · see citing works
Bromberg, J. S., Hittle, L., Xiong, Y., Saxena, V., Smyth, E. M., Li, L., Zhang, T., Wagner, C., Fricke, W. F., Simon, T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121045 · Cited by 73 · see citing works
C-reactive protein is linked to lower cognitive performance in overweight and obese women
Sweat, V., Starr, V., Bruehl, H., Arentoft, A., Tirsi, A., Javier, E., & Convit, A. (2008) · Inflammation · doi:10.1007/s10753-008-9065-3 · Cited by 72 · see citing works
Postpartum depression and vitamin D: a systematic review
Amini, S., Jafarirad, S., & Amani, R. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1423276 · Cited by 72 · see citing works
Herder, C., SCHMITT, A. J., Budden, F., Reimer, A., Kulzer, B., Roden, M., Haak, T., & Hermanns, N. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0009-2 · Cited by 71 · see citing works
Antiviral Effect of Interferon Covalently Bound to Sepharose
Ankel, H., Chany, C., Galliot, B., Chevalier, M. J., & Robert, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2360 · Cited by 70 · see citing works
Mao, R., Zhang, C., Chen, J., Zhao, G., Zhou, R., Wang, F., Xu, J., Yang, T., Su, Y., Huang, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.115 · Cited by 68 · see citing works
DNA methylation and inflammation marker profiles associated with a history of depression
Crawford, B., Craig, Z., Mansell, G., White, I., Smith, A. R., Spaull, S. R., Imm, J. L., Hannon, E. J., Wood, A. R., Yaghootkar, H., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy199 · Cited by 67 · see citing works
Induced regulatory T cells: mechanisms of conversion and suppressive potential
Dons, E. M., Raimondi, G., Cooper, D. K. C., & Thomson, A. W. (2012) · Human Immunology · doi:10.1016/j.humimm.2011.12.011 · Cited by 64 · see citing works
Kast, R. E. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00093-8 · Cited by 62 · see citing works
Gupta, R., Gupta, K., Tripathi, A. K., Bhatia, M. S., & Gupta, L. K. (2016) · Pharmacology · doi:10.1159/000444220 · Cited by 61 · see citing works
Ramírez, G., Toro, R., Döbeli, H., & von Bernhardi, R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.007 · Cited by 60 · see citing works
Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial
Del Grande da Silva, G., Wiener, C. D., Barbosa, L. P., Gonçalves Araujo, J. M., Molina, M. L., San Martin, P., Oses, J. P., Jansen, K., Dias de Mattos Souza, L., & Azevedo da Silva, R. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.008 · Cited by 60 · see citing works
Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., & Pollm�cher, T. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2038-9 · Cited by 60 · see citing works
Self-citationThe causes and consequences of variation in human cytokine production in health
Schirmer, M., Kumar, V., Netea, M. G., & Xavier, R. J. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.012 · Cited by 58 · see citing works
Himmerich, H. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.16.1739 · Cited by 57 · see citing works
Self-citationMeaselle, J. R., & Ablow, J. C. (2017) · Attachment & Human Development · doi:10.1080/14616734.2017.1362657 · Cited by 57 · see citing works
Complex Relationships Between Food, Diet, and the Microbiome
Pace, L., & Crowe, S. E. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.02.004 · Cited by 56 · see citing works
Juncal-Ruiz, M., Riesco-Dávila, L., Ortiz-García de la Foz, V., Martínez-Garcia, O., Ramírez-Bonilla, M., Ocejo-Viñals, J. G., Leza, J. C., López-Hoyos, M., & Crespo-Facorro, B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.039 · Cited by 55 · see citing works
Raj, R. V., Hamadani, M., Szabó, A., Pasquini, M. C., Shah, N. N., Drobyski, W. R., Shaw, B. E., Saber, W., Rizzo, J. D., Jerkins, J. H., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.04.010 · Cited by 55 · see citing works
The Association Between Bereavement and Biomarkers of Inflammation
Cohen, M. W., Granger, S. J. R., & Fuller‐Thomson, E. (2013) · Behavioral Medicine · doi:10.1080/08964289.2013.866539 · Cited by 54 · see citing works
Unemployment and ill health: a connection through inflammation?
Hintikka, J. J., Lehto, S. M., NISKANEN, L. K., Huotari, A., Herzig, K., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Sinikallio, S., & Viinamäki, H. T. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-410 · Cited by 54 · see citing works
Murakami, Y., Ishibashi, T., Tomita, E., Imamura, Y., Tashiro, T., Watcharanurak, K., Nishikawa, M., Takahashi, Y., Takakura, Y., Mitani, S., et al. (2016) · Scientific Reports · doi:10.1038/srep29920 · Cited by 52 · see citing works
Increased Cytokine Production by Peripheral Blood Mononuclear Cells from Healthy Elderly Peoplea
FAGIOLO, U., COSSARIZZA, A., SANTACATERINA, S., ORTOLANI, C., MONTI, D., PAGANELLI, R., & FRANCESCHI, C. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb38712.x · Cited by 52 · see citing works
Kristiansson, M., Sörman, K., Tekwe, C. D., & Calderón‐Garcidueñas, L. (2015) · Environmental Research · doi:10.1016/j.envres.2015.05.013 · Cited by 49 · see citing works
Cheon, Y., Lee, S., Kim, M., Kim, H. O., Suh, Y. S., Ki‐Soo, P., Kim, R. B., Yang, H.-S., Kim, J., Son, C., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.012 · Cited by 49 · see citing works
Pathway analysis of genome‐wide association datasets of personality traits
Kim, H. ‐., Kim, B. ‐., Cho, J. K., Ryu, S., Shin, H. R., Sung, J., Shin, C., Cho, N. H., Sung, Y. A., Choi, B., et al. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12212 · Cited by 46 · see citing works
The production of interferon in brains of mice infected with an arthropod-borne virus
Hitchcock, G., & Porterfield, J. S. (1961) · Virology · doi:10.1016/0042-6822(61)90155-6 · Cited by 45 · see citing works
Role of Neuroinflammation in Evolution of Childhood Epilepsy
Koh, S. (2017) · Journal of Child Neurology · doi:10.1177/0883073817739528 · Cited by 42 · see citing works
IL-4–producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases
Hurdayal, R., Ndlovu, H., Revaz‐Breton, M., Parihar, S. P., Nono, J. K., Govender, M., & Brombacher, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708125114 · Cited by 41 · see citing works
Protection of mice against the lethal action of an encephalitis virus
Hitchcock, G., & Isaacs, A. (1960) · BMJ · doi:10.1136/bmj.2.5208.1268 · Cited by 40 · see citing works
Sousa, A. N., Raposo, F. J. A., Fonseca, S., Valente, L., Duarte, F., Gonçalves, M., Tuna, D., & Paiva, J.-A. (2015) · Disease Markers · doi:10.1155/2015/747036 · Cited by 40 · see citing works
Involvement of genetic factors in bipolar disorders: current status.
Weschenfelder, J., Sander, C., Kluge, M., Kirkby, K. C., & Himmerich, H. (2012) · PubMed · Cited by 40 · see citing works
Self-citationThe role of <scp>IL</scp>‐22 in the resolution of sterile and nonsterile inflammation
Alabbas, S. Y., Begun, J., Florin, T. H., & Oancea, I. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1017 · Cited by 37 · see citing works
Schmidt, F. M., Kirkby, K. C., & Himmerich, H. (2014) · PubMed · Cited by 37 · see citing works
Self-citationLackie, J. M. (2010) · Oxford University Press eBooks · doi:10.1093/acref/9780199549351.001.0001 · Cited by 37 · see citing works
Preanalytical factors and the measurement of cytokines in human subjects
Dugué, B., Leppänen, E., & Gräsbeck, R. (1996) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592351 · Cited by 35 · see citing works
Song, C., Luchtman, D. W., Kang, Z., Tam, E. M., Yatham, L. N., Su, K., & Lam, R. W. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.003 · Cited by 35 · see citing works
Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine
Tilg, H., & Peschel, C. (1996) · Leukemia & Lymphoma · doi:10.3109/10428199609054802 · Cited by 34 · see citing works
Anti-Inflammatory Drugs in Psychiatry
Berthold‐Losleben, M., Heitmann, S., & Himmerich, H. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809789352221 · Cited by 32 · see citing works
Self-citationSchmidt, F. M., Pschiebl, A., Sander, C., Kirkby, K. C., Thormann, J., Minkwitz, J., Chittka, T., Weschenfelder, J., Holdt, L. M., Teupser, D., et al. (2016) · Neuropsychobiology · doi:10.1159/000441190 · Cited by 28 · see citing works
Self-citationManagement of Depression After Myocardial Infarction
Shapiro, P. A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0634-4 · Cited by 28 · see citing works
Department of Psychological Medicine, K. C. L., Hussein, S., Himmerich, H., Department of Psychiatry, P. A. P., Willmund, G. D., Department of Psychiatry, P. A. P., Ibrahim, M. A. A., Department of Immunological Medicine and Allergy, K. H. P., Dalton, B., & Department of Psychological Medicine, K. C. L. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.407 · Cited by 26 · see citing works
Self-citationEthemoğlu, Ö., Ay, H., Koyuncu, İ., & Gönel, A. (2018) · Seizure · doi:10.1016/j.seizure.2018.06.009 · Cited by 25 · see citing works
Thormann, J., Chittka, T., Minkwitz, J., Kluge, M., & Himmerich, H. (2013) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0032-1330351 · Cited by 25 · see citing works
Self-citationWaheed, A., Dalton, B., Wesemann, U., Ibrahim, M. A. A., & Himmerich, H. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2017.0088 · Cited by 23 · see citing works
Self-citationFacharztwissen Psychiatrie, Psychosomatik und Psychotherapie
Schneider, F. W. (2017) · Springer eBooks · doi:10.1007/978-3-662-50345-4 · Cited by 23 · see citing works
Koch, K., Ye, K., Clark, B. D., & Dinarello, C. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220123 · Cited by 22 · see citing works
Bruserud, Ø., Hamann, W., Patel, S., Ehninger, G., & Pawelec, G. (1992) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1992.tb01589.x · Cited by 21 · see citing works
Burgey, C., Kern, W. V., Römer, W., Sakιnç, T., & Rieg, S. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.01.005 · Cited by 20 · see citing works
Innate lymphoid cell-derived cytokines in autoimmune diseases
Li, S., Yang, D., Peng, T., Wu, Y., Tian, Z., & Ni, B. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.05.001 · Cited by 19 · see citing works
[A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].
Kasakura, S. (1998) · PubMed · Cited by 19 · see citing works
Steinberg, H., & Himmerich, H. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.623717 · Cited by 17 · see citing works
Self-citationPharmacological treatment for psychotic depression
Wijkstra, J., Lijmer, J. G., Burger, H., Geddes, J. R., & Nolen, W. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004044.pub3 · Cited by 17 · see citing works
Immune and neuroendocrine correlates of temperament in infancy
O’Connor, T. G., Scheible, K. M., Sefair, A. V., Gilchrist, M., Blackmore, E. R., Winter, M. A., Gunnar, M. R., Wyman, C. P., Carnahan, J. A., Moynihan, J. A., et al. (2017) · Development and Psychopathology · doi:10.1017/s0954579417001250 · Cited by 17 · see citing works
Flagged first, then by citations
1 of the 229 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Himmerich, 2014, Prävention psychischer Erkrankungen am Beispiel der Depression, 166
- Weschenfelder, 2012, The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems, Psychiatr Danub., 24, 112
Cited by
Sorted by citations
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T. J., & Peteet, J. R. (2023) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,150 · see citing works
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda‐Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 534 · see citing works
Correia, A. S., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158493 · Cited by 356 · see citing works
Liu, R. T., Rowan-Nash, A. D., Sheehan, A. E., Walsh, R. F. L., Sanzari, C. M., Korry, B. J., & Belenky, P. A. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.026 · Cited by 244 · see citing works
Nettis, M. A., Lombardo, G., Hastings, C., Zajkowska, Z., Mariani, N., Nikkheslat, N., Worrell, C., Enache, D., McLaughlin, A., Kose, M., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00948-6 · Cited by 235 · see citing works
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Roohi, E., Jaafari, N., & Hashemian, F. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02100-7 · Cited by 235 · see citing works
Depression, dementia and immune dysregulation
Hayley, S., Hakim, A. M., & Albert, P. R. (2021) · Brain · doi:10.1093/brain/awaa405 · Cited by 186 · see citing works
Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Sălcudean, A., Bodo, C.-R., Popovici, R. A., Lica, M. M., Păcurar, M., Crăciun, R.-E., Crișan, A., ENĂTESCU, V. R., Marinescu, I. P., Cîmpian, D. M., et al. (2025) · Biomolecules · doi:10.3390/biom15040502 · Cited by 165 · see citing works
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Mishra, A., Bandopadhyay, R., Singh, P. K., Mishra, P. S., Sharma, N., & Khurana, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00806-4 · Cited by 132 · see citing works
The Developing Microbiome From Birth to 3 Years: The Gut-Brain Axis and Neurodevelopmental Outcomes
Laue, H. E., Coker, M. O., & Madan, J. C. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.815885 · Cited by 106 · see citing works
Saccaro, L. F., Schilliger, Z., Dayer, A. G., Perroud, N. A., & Piguet, C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.017 · Cited by 104 · see citing works
Inflammation, Anxiety, and Stress in Attention-Deficit/Hyperactivity Disorder
Saccaro, L. F., Schilliger, Z., Perroud, N. A., & Piguet, C. (2021) · Biomedicines · doi:10.3390/biomedicines9101313 · Cited by 103 · see citing works
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works
Neuroinflammation, Pain and Depression: An Overview of the Main Findings
Campos, A. C. P., Antunes, G. F., Matsumoto, M., Pagano, R. L., & Martinez, R. C. R. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01825 · Cited by 102 · see citing works
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways
Toenders, Y. J., Laskaris, L., Davey, C. G., Berk, M., Milaneschi, Y., Lamers, F., Penninx, B. W. J. H., & Schmaal, L. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01306-8 · Cited by 98 · see citing works
Böttcher, C., Fernández‐Zapata, C., Snijders, G. J. L., Schlickeiser, S., Sneeboer, M. A. M., Kunkel, D., de Witte, L. D., & Priller, J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00992-2 · Cited by 91 · see citing works
Sharma, S., Chawla, S., Kumar, P., Ahmad, R., & Verma, P. K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149123 · Cited by 97 · see citing works
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Petralia, M. C., Mazzon, E., Fagone, P., Basile, M. S., Lenzo, V., Quattropani, M. C. A., Nuovo, S. D., Bendtzen, K., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102504 · Cited by 86 · see citing works
Is depression the missing link between inflammatory mediators and cancer?
Polityńska, B., Pokorska, O., Wojtukiewicz, A. M., Sawicka, M., Mysliwiec, M., Honn, K. V., Tucker, S. C., & Wojtukiewicz, M. Z. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108293 · Cited by 80 · see citing works
Neuroinflammatory basis of depression: learning from experimental models
Afridi, R., & Suk, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.691067 · Cited by 82 · see citing works
Gammon, D., Cheng, C. M. C., Volkovinskaia, A., Baker, G. B., & Dursun, S. M. (2021) · Biomolecules · doi:10.3390/biom11071030 · Cited by 79 · see citing works
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 86 · see citing works
Rahimian, R., Belliveau, C., Chen, R., & Mechawar, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871997 · Cited by 73 · see citing works
Unraveling the Complex Interplay Between Neuroinflammation and Depression: A Comprehensive Review
Sălcudean, A., Popovici, R. A., Pitic, D. E., Sârbu, D., Boroghina, A. R., Jomaa, M., Salehi, M. A., Kher, A. A. M., Lica, M. M., Bodo, C. R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041645 · Cited by 76 · see citing works
Chen, M., Kao, Z.-K., Chang, W.-C., Tu, P., Hsu, J.-W., Huang, K., Su, T., Li, C., Lin, W.-C., Tsai, S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.158 · Cited by 68 · see citing works
Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
Reyes-Martínez, S., Segura-Real, L., Gómez-García, A. P., Tesoro-Cruz, E., Constantino-Jonapa, L. A., Amedei, A., & Aguirre‐García, M. M. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203065 · Cited by 75 · see citing works
Sen, Z. D., Danyeli, L. V., Woelfer, M., Lamers, F., Wagner, G., Sobanski, T., & Walter, M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.020 · Cited by 65 · see citing works
Inflammation as the Potential Basis in Depression
Maeng, S., & Hong, H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938226.113 · Cited by 61 · see citing works
Park, H. J., Kim, S. A., Kang, W. S., & Kim, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041899 · Cited by 59 · see citing works
Zhao, Z., Wang, B., Mu, L., Wang, H., Luo, J., Yang, Y., Yang, H., Li, M., Zhou, L., & Tao, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00258 · Cited by 57 · see citing works
Juncal-Ruiz, M., Riesco-Dávila, L., Ortiz-García de la Foz, V., Martínez-Garcia, O., Ramírez-Bonilla, M., Ocejo-Viñals, J. G., Leza, J. C., López-Hoyos, M., & Crespo-Facorro, B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.039 · Cited by 55 · see citing works
Advancing electrochemical biosensors for interleukin-6 detection
McCrae, L. E., Ting, W., & Howlader, M. M. R. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100288 · Cited by 55 · see citing works
Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Jembrek, M. J., Oršolić, N., Karlović, D., & Peitl, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086888 · Cited by 54 · see citing works
Tonhajzerová, I., Sekaninova, N., Olexova, L. B., & Višňovcová, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072317 · Cited by 61 · see citing works
Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
Bouças, A. P., Rheinheimer, J., & Lagopoulos, J. (2020) · The Neuroscientist · doi:10.1177/1073858420967892 · Cited by 51 · see citing works
Liu, Q., Zhang, M., Guo, M.-X., Zhang, Q., Li, N.-Z., Cheng, J., Wang, S.-L., Xu, G., Li, C., Zhu, J., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10037-0 · Cited by 50 · see citing works
A tale of two transmitters: serotonin and histamine as in vivo biomarkers of chronic stress in mice
Hersey, M., Reneaux, M., Berger, S. N., Mena, S., Buchanan, A. M., Ou, Y., Tavakoli, N. S., Reagan, L. P., Claudia Clopath, A., & Hashemi, P. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02508-9 · Cited by 52 · see citing works
Zhang, Y., Yang, Y., Li, H., Feng, Q., Ge, W., & Xu, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03563-w · Cited by 54 · see citing works
Chong, P. S., Poon, C. H., Roy, J., Tsui, K. C., Lew, S. Y., Phang, M. W. L., Tan, R. J. Y., Cheng, P. G., Fung, M., Wong, K.-H., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00546-8 · Cited by 49 · see citing works
Brain–immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders
Zhao, F., Li, B., Yang, W., Ge, T., & Cui, R. (2022) · Cell Proliferation · doi:10.1111/cpr.13295 · Cited by 47 · see citing works
Inflammatory Markers in Substance Use and Mood Disorders: A Neuroimaging Perspective
Agarwal, K., Manza, P., Chapman, M., Nawal, N., Biesecker, E., McPherson, K. L., Dennis, E., Johnson, A., Volkow, N. D., & Joseph, P. V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.863734 · Cited by 51 · see citing works
The Mind Body Connection in Dermatologic Conditions: A Literature Review
Mar, K., & Rivers, J. K. (2023) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754231204295 · Cited by 54 · see citing works
Serum Interferon-Gamma Level Is Associated with Drug-Naïve Major Depressive Disorder
Daria, S., Proma, M. A., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974169 · Cited by 46 · see citing works
Liu, X., Chen, W., Wang, C., Liu, W., Hayashi, T., Mizuno, K., Hattori, S., Fujisaki, H., & Ikejima, T. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113593 · Cited by 46 · see citing works
Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Gędek, A., Szular, Z., Antosik-Wójcińska, A. Z., Mierzejewski, P., & Dominiak, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103497 · Cited by 46 · see citing works
Relationships between inflammatory markers and suicide risk status in major depression
Ganança, L., Galfalvy, H., Cisneros-Trujillo, S., Basseda, Z., Cooper, T. B., Ren, X., Figueira, M. L., Oquendo, M. A., Mann, J. J., & Sublette, M. E. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.029 · Cited by 46 · see citing works
Stolfi, F., Abreu, H., Sinella, R., Nembrini, S., Centonze, S., Landra, V., Brasso, C., Cappellano, G., Rocca, P., & Chiocchetti, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1422939 · Cited by 49 · see citing works
Alvarez-Mon, M. A., Gomez-Lahoz, A. M., Orozco, A., Lahera, G., Sosa-Reina, M. D., Diaz, D., Albillos, A., Quintero, J., Molero, P., Monserrat, J., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.591962 · Cited by 44 · see citing works
A longitudinal analysis of cytokines in anorexia nervosa
Dalton, B., Leppänen, J., Campbell, I. C., Chung, R., Breen, G. D., Schmidt, U. H., & Himmerich, H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.012 · Cited by 43 · see citing works
Self-citationPersonalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
Perna, G., Alciati, A., Daccò, S., Grassi, M., & Caldirola, D. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0289 · Cited by 47 · see citing works
Recent Advances in Aptasensor for Cytokine Detection: A Review
Kim, J., Noh, S., Park, J. A., Park, S. C., Park, S. J., Lee, J., Ahn, J., & Lee, T. (2021) · Sensors · doi:10.3390/s21248491 · Cited by 42 · see citing works
Immune Tolerance as the Physiologic Counterpart of Chronic Inflammation
Rogovskii, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02061 · Cited by 41 · see citing works
Rasheed, M., Asghar, R., Firdoos, S., Ahmad, N., Nazir, A., Ullah, K. M., Li, N., Zhuang, F., Chen, Z., & Deng, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031294 · Cited by 41 · see citing works
Liu, H., Lin, Y., Tsai, M.-C., Wu, Y., & Lee, M.-C. (2022) · Antioxidants · doi:10.3390/antiox11050947 · Cited by 40 · see citing works
Abdallah, M. S., Mosalam, E. M., Zidan, A. A., El-Attar, K. S., Zaki, S. A., Ramadan, A. N., & Ebeid, A. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00878-7 · Cited by 40 · see citing works
RetractedThe Cytokine IL-17A as a Marker of Treatment Resistance in Major Depressive Disorder?
Nothdurfter, C., Milenkovic, V. M., Sarubin, N., Hilbert, S., Manook, A., Weigl, J., Almeqbaali, K., Wetzel, C. H., Rupprecht, R., & Baghai, T. C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14636 · Cited by 38 · see citing works
Neuropsychiatric Correlates of Narcolepsy
BaHammam, A. S., Alnakshabandi, K., & Pandi-Perumal, S. R. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01159-y · Cited by 38 · see citing works
Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation
Methiwala, H. N., Vaidya, B., Addanki, V. K., Bishnoi, M., Sharma, S. S., & Kondepudi, K. K. (2021) · Food & Function · doi:10.1039/d0fo02855j · Cited by 38 · see citing works
Shen, H., Deng, Z., Li, Z., Gao, W., Zeng, D., Shi, Y., Zhao, N., Xu, F., Li, T., Li, H., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.005 · Cited by 38 · see citing works
Bonanno, M., Papa, D., Cerasa, A., Maggio, M. G., & Calabrò, R. S. (2024) · Medicina · doi:10.3390/medicina60020285 · Cited by 40 · see citing works
Mood and microbes: a comprehensive review of intestinal microbiota’s impact on depression
Luqman, A., He, M., Hassan, A., Ullah, M., Zhang, L., Khan, M. R., Din, A. U., Ullah, K., Wang, W. J., & Wang, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1295766 · Cited by 38 · see citing works
SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?
Zhang, Y., Anoopkumar‐Dukie, S., & Davey, A. K. (2021) · Biomolecules · doi:10.3390/biom11030353 · Cited by 36 · see citing works
Lee, H., Song, M., Lee, J., Kim, J.-B., & Lee, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.125 · Cited by 35 · see citing works
Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling
Harini, K., Alomar, S. Y., Mohammed, V., Manoharadas, S., Thirumalai, A., Girigoswami, K., & Girigoswami, A. (2024) · Pharmaceuticals · doi:10.3390/ph17030366 · Cited by 34 · see citing works
Pro-inflammatory cytokines and suicidal behavior among patients with bipolar I disorder
Huang, M., Chen, M., Chan, Y. E., Li, C., Tsai, S., Bai, Y., & Su, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.030 · Cited by 29 · see citing works
Early-diagnosis of major depressive disorder: From biomarkers to point-of-care testing
Zhang, X., Zhang, Z., Diao, W., Zhou, C., Song, Y., Wang, R., Luo, X., & Liu, G. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116904 · Cited by 30 · see citing works
Timiș, T. L., Beni, L., Mocan, T., Florian, I. A., & Orăsan, R.-I. (2023) · Life · doi:10.3390/life13051219 · Cited by 30 · see citing works
Kang, Y., Shin, D., Kim, A., You, S., Kim, B., Han, K., & Ham, B. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.071 · Cited by 29 · see citing works
Li, Y., Yue, Y., Chen, S., Jiang, W., Xu, Z., Chen, G., Zhu, Z., Tan, L., & Yuan, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.935031 · Cited by 29 · see citing works
Mehralizadeh, H., Nazari, A., Oruji, F., Roostaie, M., Hosseininozari, G., Yazdani, O., Esbati, R., & Roudini, K. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154528 · Cited by 29 · see citing works
Lespérance, P., Jodoin, V. D., Drouin, D., Racicot, F., Miron, J., Longpré-Poirier, C., Fournier‐Gosselin, M., Thébault, P., Lapointe, R., Arbour, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052679 · Cited by 28 · see citing works
Schmidt, F. M., Koch, J., Nowak, C., Holdt, L. M., Teupser, D., Hegerl, U., & Himmerich, H. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.09.010 · Cited by 27 · see citing works
Self-citationHashikawa‐Hobara, N., Otsuka, A., Okujima, C., & Hashikawa, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.918953 · Cited by 27 · see citing works
New insights into anti-depression effects of bioactive phytochemicals
Zhao, R., Wang, J., Chung, S. K., & Xu, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107566 · Cited by 25 · see citing works
He, S., Chen, X.-X., Ge, W., Yang, S., Chen, J., Niu, J.-W., Xia, L., & Chen, G. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s312272 · Cited by 25 · see citing works
Tsai, M.-K., Sytwu, H., Hsieh, T., Chien, W., Lai, C.-H., & Chen, H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s355314 · Cited by 26 · see citing works
VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 26 · see citing works
Can animals develop depression? An overview and assessment of ‘depression-like’ states
MacLellan, A., Fureix, C., Polanco, A., & Mason, G. J. (2021) · Behaviour · doi:10.1163/1568539x-bja10132 · Cited by 23 · see citing works
Depressive disorder and antidepressants from an epigenetic point of view
Arčan, I. Š., Kouter, K., & Paska, A. V. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i9.1150 · Cited by 25 · see citing works
Batsukh, S., Oh, S., Rheu, K.-M., Lee, B.-J., Park, C. H., Son, K. H., & Byun, K. (2022) · Nutrients · doi:10.3390/nu14245382 · Cited by 23 · see citing works
Liver and inflammatory biomarker relationships to depression symptoms in healthy older adults
Savage, K. M., Porter, C., Bunnett, E. R., Hana, M., Keegan, A. P., Ogden, E., Stough, C. K. K., & Pipingas, A. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112186 · Cited by 25 · see citing works
Baldofski, S., Mauche, N., Dogan-Sander, E., Bot, M., Brouwer, I. A., Paans, N. P. G., Cabout, M., Gili, M., van Grootheest, G., Hegerl, U., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00858 · Cited by 23 · see citing works
Sekaninova, N., Olexova, L. B., Višňovcová, Z., Ondrejka, I., & Tonhajzerová, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197302 · Cited by 23 · see citing works
Daphnetin, a natural coumarin averts reserpine-induced fibromyalgia in mice: modulation of MAO-A
Singh, L., Kaur, A., Singh, A., & Bhatti, R. (2021) · Experimental Brain Research · doi:10.1007/s00221-021-06064-1 · Cited by 22 · see citing works
Neuroinflammation Profiling of Brain Cytokines Following Repeated Blast Exposure
Heyburn, L., Batuure, A., Wilder, D. M., Long, J. B., & Sajja, V. S. S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612564 · Cited by 22 · see citing works
Reduced MIP-1β as a Trait Marker and Reduced IL-7 and IL-12 as State Markers of Anorexia Nervosa
Keeler, J. L., Patsalos, O., Chung, R., Schmidt, U. H., Breen, G. D., Treasure, J. L., Himmerich, H., & Dalton, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080814 · Cited by 22 · see citing works
Self-citationDeonaraine, K. K., Wang, Q., Cheng, H., Chan, K. L., Lin, H., Liu, K., Parise, L. F., Cathomas, F., Leclair, K. B., Flanigan, M. E., et al. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24724 · Cited by 21 · see citing works
Abdelkawy, Y. S., Elharoun, M., Sheta, E., Abdel-Raheem, I. T., & Nematalla, H. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176525 · Cited by 21 · see citing works
Ye, M., Ji, F., Huang, C., Li, F., Zhang, C., Zhang, Y., Wang, R., Ma, K., Xu, L., & Wang, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1398292 · Cited by 22 · see citing works
Himmerich, H., Keeler, J. L., King, J. A., Ehrlich, S., Kaufmann, L., Bulik, C. M., Cohen‐Woods, S., Wade, T. D., Steiger, H., Booij, L., et al. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2626934 · Cited by 22 · see citing works
Self-citationPsoriatic arthritis: prospects for the future
Hackett, S., Ogdie, A., & Coates, L. C. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221086710 · Cited by 20 · see citing works
Parment, R., Dubois, M., Desrues, L., Mutel, A., Dembélé, K.-P., Belin, N., Tron, L., Guérin, C., Coëffier, M., Compère, V., et al. (2022) · Cancers · doi:10.3390/cancers14184403 · Cited by 20 · see citing works
Biomarker opportunities in the treatment of cancer-related depression
Panjwani, A. A., Aguiar, S., Gascon, B., Brooks, D. G., & Li, M. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.10.003 · Cited by 21 · see citing works
Pethő, B., Kovács, M. Á., Simon, D., Tóth, T., Hajnal, A. S., Csulak, T., Hebling, D., Albert, N., Varga, E., Herold, M., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1321354 · Cited by 22 · see citing works
Yang, S., Han, J., Ye, Z., Zhou, H., Yan, Y., Han, D., Chen, S., Wang, L., Feng, Q., Zhao, X., et al. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-024-02579-4 · Cited by 19 · see citing works
Deore, R., Ansari, R., Awathale, S. N., Shelke, M., Badwaik, H., Goyal, S. N., & Nakhate, K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176707 · Cited by 21 · see citing works
Sakurai, K., Itou, T., Morita, M., Kasahara, E., Moriyama, T., Macpherson, T., Ozawa, T., Miyamoto, Y., Yoneda, Y., Sekiyama, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258364 · Cited by 18 · see citing works
Li, X., Liu, T., Mo, X., Wang, R., Kong, X., Shao, R., McIntyre, R. S., So, K., & Lin, K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389360 · Cited by 18 · see citing works
Koreki, A., Sado, M., Mitsukura, Y., Tachimori, H., Kubota, A., Kanamori, Y., Uchibori, M., Usune, S., Ninomiya, A., Shirahama, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70834-4 · Cited by 18 · see citing works
- Authors
- Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B.
- Affiliations
- King's College London (GB)
- Maidstone and Tunbridge Wells NHS Trust (GB)
- Kings Health Partners (GB)
- Corresponding author
- Himmerich, Hubertus
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2019-02-07
- Volume
- 10
- Pages
- 30-30
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC6374304
- OpenAlex
- W2912456649
- Cited by
- 313
- References
- 229
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 42 · 2023: 85 · 2022: 45 · 2021: 52 · 2020: 35 · 2019: 8 · 2018: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- South London and Maudsley NHS Foundation Trust
- King's College London
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- depression, cytokines, inflammatory cytokines, anti-inflammatory cytokines, interleukin-6, IL-10, TNF-α, interferon-gamma, antidepressant treatment, mirtazapine, weight gain, biomarkers, cytokine signaling, depression subtypes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review